<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7865633</article-id><article-id pub-id-type="pmid">33530467</article-id><article-id pub-id-type="doi">10.3390/molecules26030632</article-id><article-id pub-id-type="publisher-id">molecules-26-00632</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Romeo</surname><given-names>Isabella</given-names></name><xref ref-type="aff" rid="af1-molecules-26-00632">1</xref><xref ref-type="aff" rid="af2-molecules-26-00632">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9968-4996</contrib-id><name><surname>Mesiti</surname><given-names>Francesco</given-names></name><xref ref-type="aff" rid="af2-molecules-26-00632">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0870-2376</contrib-id><name><surname>Lupia</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="af2-molecules-26-00632">2</xref></contrib><contrib contrib-type="author"><name><surname>Alcaro</surname><given-names>Stefano</given-names></name><xref ref-type="aff" rid="af1-molecules-26-00632">1</xref><xref ref-type="aff" rid="af2-molecules-26-00632">2</xref><xref rid="c1-molecules-26-00632" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Mu&#x000f1;oz-Torrero</surname><given-names>Diego</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>De Pascual-Teresa</surname><given-names>Beatriz</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-26-00632"><label>1</label>Dipartimento di Scienze della Salute, Universit&#x000e0; &#x0201c;Magna Gr&#x000e6;cia&#x0201d; di Catanzaro, Campus &#x0201c;S. Venuta&#x0201d;, Viale Europa, 88100 Catanzaro, Italy; <email>isabella.romeo@unicz.it</email></aff><aff id="af2-molecules-26-00632"><label>2</label>Net4Science Academic Spin-Off, Universit&#x000e0; &#x0201c;Magna Gr&#x000e6;cia&#x0201d; di Catanzaro, Campus &#x0201c;S. Venuta&#x0201d;, Viale Europa, 88100 Catanzaro, Italy; <email>francesco.mesiti@studenti.unicz.it</email> (F.M.); <email>antonio.lupia@net4science.com</email> (A.L.)</aff><author-notes><corresp id="c1-molecules-26-00632"><label>*</label>Correspondence: <email>alcaro@unicz.it</email>; Tel.: +39-0961-3694198</corresp></author-notes><pub-date pub-type="epub"><day>26</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2021</year></pub-date><volume>26</volume><issue>3</issue><elocation-id>632</elocation-id><history><date date-type="received"><day>31</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>21</day><month>1</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been identified in China as the etiologic agent of the recent COVID-19 pandemic outbreak. Due to its high transmissibility, this virus quickly spread throughout the world, causing considerable health issues. The scientific community exerted noteworthy efforts to obtain therapeutic solutions for COVID-19, and new scientific networks were constituted. No certified drugs to efficiently inhibit the virus were identified, and the development of de-novo medicines requires approximately ten years of research. Therefore, the repurposing of natural products could be an effective strategy to handle SARS-CoV-2 infection. This review aims to update on current status of the natural occurring compounds recognizing SARS-CoV-2 druggable targets. Among the clinical trials actually recruited, some natural compounds are ongoing to examine their potential role to prevent and to treat the COVID-19 infection. Many natural scaffolds, including alkaloids, terpenes, flavonoids, and benzoquinones, were investigated by in-silico, in-vitro, and in-vivo approaches. Despite the large data set obtained by a computational approach, experimental evidences in most cases are not available. To fill this gap, further efforts to validate these results are required. We believe that an accurate investigation of naturally occurring compounds may provide insights for the potential treatment of COVID-19 patients.</p></abstract><kwd-group><kwd>SARS-CoV-2</kwd><kwd>natural products</kwd><kwd>drug repurposing</kwd><kwd>multi-targeting</kwd><kwd>COVID-19</kwd><kwd>in silico</kwd><kwd>in vitro</kwd><kwd>in vivo</kwd><kwd>clinical trials</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-26-00632"><title>1. Introduction</title><p>Coronaviruses are a diverse panel of viruses capable of producing infection in many animals and are responsible for respiratory infections in humans. After facing the fatal respiratory illness, caused by the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV), the end of 2019 marked the start of one of the worse global pandemics [<xref rid="B1-molecules-26-00632" ref-type="bibr">1</xref>]. More precisely, the first outbreak was beheld in Wuhan city, probably in the local seafood market, where there was witnessed a wave of noteworthy suspected pneumonia disease that began with progressive respiratory failure due to alveolar damage and even death. Successively, this &#x0201c;enemy&#x0201d; has been identified in SARS-CoV-2 as an etiologic agent of coronavirus disease 2019 [<xref rid="B2-molecules-26-00632" ref-type="bibr">2</xref>]. SARS-CoV-2 is still a global health problem today. Due to its high transmissibility, the virus was able to spread quickly around the world [<xref rid="B3-molecules-26-00632" ref-type="bibr">3</xref>].</p><p>On 11 March 2020, the World Health Organization (WHO) declared the coronavirus disease, namely COVID-19, a pandemic and the scientific community shifted its focus towards this fight. Today, there is no proven effective and specific treatment for COVID-19. However, a sign of the extraordinary commitment carried out by researchers around the world is provided by recently published scientific evidences. Suffice it to say that the word &#x0201c;SARS-CoV-2&#x0201d; is reported on PubMed in 45,860 scientific articles, with reference date as the end of December 2020, demonstrating how the scientific community has conducted intensive research on this emergent topic. However, it is also well known that the development of specific <italic>de-novo</italic> antiviral therapies generally takes from 10 to 17 years, while for particular vaccine production it should be necessary to wait for a timeframe of approximately 12&#x02013;18 months.</p><p>In December 2020, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 (BNT162b2) vaccine (Pfizer, Inc; Philadelphia, Pennsylvania). This vaccine is a lipid nanoparticle-formulated nucleoside-modified mRNA vaccine encoding the prefusion Spike glycoprotein of SARS-CoV-2.</p><p>Despite the ultracold-chain storage and requirements for handling and administration, this vaccine will be feasible to implement. Still, these requirements could limit its availability to some populations, thereby negatively impacting health equity. In this perspective, scientific efforts should be made to overcome these challenges and advance health equity [<xref rid="B4-molecules-26-00632" ref-type="bibr">4</xref>].</p><p>An issue to emphasize is the importance of the network between experts in complementary disciplines involved in COVID-19 investigation. In this connection, a trans-European Cooperation in Science and Technology (COST) action network is currently promoting scientific collaborations to speed up the achievements against COVID-19 [<xref rid="B5-molecules-26-00632" ref-type="bibr">5</xref>].</p><p>Another main point is represented by the evolution and the adaptive mutations of the virus [<xref rid="B6-molecules-26-00632" ref-type="bibr">6</xref>]. Indeed, the presence of SARS-CoV-2 Spike mutations can affect the interaction with the human epithelial cell receptors Angiotensin Converting Enzyme 2 (ACE2). The question of whether this would correspond to a novel and more potent COVID-19 specificities eventually requiring the development of wider-spectrum anti-SARS-CoV-2 strategies, such as vaccines or antiviral drugs, remains open [<xref rid="B7-molecules-26-00632" ref-type="bibr">7</xref>,<xref rid="B8-molecules-26-00632" ref-type="bibr">8</xref>,<xref rid="B9-molecules-26-00632" ref-type="bibr">9</xref>].</p><p>Hence, the repurposing of clinically evaluated drugs is one of the most promising strategies to address the immense landscape of diseases, including infectious ones such as COVID-19. Remarkably, while most drug repurposing occurrences are based on synthetic compounds, naturally occurring molecules may offer significant opportunities. In fact, nature itself may be considered a magic bullet providing molecules with promising or still unexplored pharmacological properties [<xref rid="B10-molecules-26-00632" ref-type="bibr">10</xref>,<xref rid="B11-molecules-26-00632" ref-type="bibr">11</xref>]. It was reported that around 80% of the human population draws on traditional plants in the developing world for health quality and requirements [<xref rid="B12-molecules-26-00632" ref-type="bibr">12</xref>,<xref rid="B13-molecules-26-00632" ref-type="bibr">13</xref>]. Moreover, natural products are considered an essential source of successful drug leads and provide unique structural diversity with respect to standard combinatorial chemistry. Since more than 95% of the world&#x02019;s biodiversity has not been evaluated for potential biological activity, the main challenge involves how to efficiently access and enhance this natural chemical diversity [<xref rid="B14-molecules-26-00632" ref-type="bibr">14</xref>,<xref rid="B15-molecules-26-00632" ref-type="bibr">15</xref>,<xref rid="B16-molecules-26-00632" ref-type="bibr">16</xref>]. Therefore, the different chemical space structural, affordability, lack of substantial toxic effects and inherent biologic properties of natural products allow to consider them good candidates for new therapeutics [<xref rid="B17-molecules-26-00632" ref-type="bibr">17</xref>,<xref rid="B18-molecules-26-00632" ref-type="bibr">18</xref>]. As a result of the current COVID-19 outbreak, the repurposing of natural products could be an effective strategy to handle the SARS-CoV-2 infection. Currently, several studies have highlighted the antiviral properties of several natural compounds [<xref rid="B12-molecules-26-00632" ref-type="bibr">12</xref>,<xref rid="B19-molecules-26-00632" ref-type="bibr">19</xref>,<xref rid="B20-molecules-26-00632" ref-type="bibr">20</xref>].</p><p>Therefore, naturally occurring molecules with broad antiviral spectrum may offer a safe, effective, and inexpensive platform for identifying novel treatment of SARS-CoV-2. To prepare this review article, the PubMed database (<uri xlink:href="www.ncbi.nlm.nih.gov/pubmed">www.ncbi.nlm.nih.gov/pubmed</uri>) was used to analyze scientific manuscripts matching the queries &#x0201c;SARS-CoV-2&#x0201d; and &#x0201c;natural products&#x0201d;.</p><p>After analyzing the compelling articles dealing with the antiviral activity of natural compounds against SARS-CoV-2, we dedicated our attention to natural compounds recognizing SARS-CoV-2 druggable targets. Particularly, natural compounds currently under clinical trials were extensively herein discussed. Due to the amount of data from scientific literature, in our opinion sometimes inaccurate and superficial, our main goal is to give a vision on the possible role of the natural compounds against SARS-CoV-2.</p><p>In this regard, based on the recent analysis gathered on SARS-CoV-2 targets [<xref rid="B21-molecules-26-00632" ref-type="bibr">21</xref>], we focused on natural compounds under clinical trials in the first section. Meanwhile, in the second section, we provided in-vitro, in-vivo and in-silico results of the natural derivatives against SARS-CoV-2. This analysis may help to figure out the most promising natural products which lead to the development of drugs for the treatment or prophylaxis of the emergent pandemic. Since the drug repurposing is a time-saving medicinal chemistry strategy, it could offer an excellent opportunity to obtain useful and non-toxic drugs to fight COVID-19.</p></sec><sec sec-type="results" id="sec2-molecules-26-00632"><title>2. Results</title><sec id="sec2dot1-molecules-26-00632"><title>2.1. Natural Occurring Compounds Undergoing Clinical Trials</title><p>The clinical severity of COVID-19 varies from asymptomatic infection to mortal disease. Despite the academic and industrial efforts for fighting SARS-CoV-2, nowadays there are no drugs for the treatment of this epidemic viral infection. Hence, the development of effective and safe drugs is urgent to control or prevent the spread of SARS-CoV-2. Natural products, which have historically been used to avoid or alleviate several diseases, are still offering molecules with promising or yet unexplored pharmacological properties from the ancient time. Natural occurring compounds are among the options being considered for the treatment of SARS-CoV-2 infection as they are commonly inexpensive, available, and rarely have shown undesirable side effects [<xref rid="B22-molecules-26-00632" ref-type="bibr">22</xref>]. In this section, we will discuss the natural compounds actually under clinical trials.</p><sec id="sec2dot1dot1-molecules-26-00632"><title>2.1.1. Vitamin D</title><p>In striving to determine a COVID-19 potential treatment, the effectiveness of <bold>vitamin D</bold> towards this endemic health issue was evaluated [<xref rid="B23-molecules-26-00632" ref-type="bibr">23</xref>]. In ancient times, food-enriched vitamin D, including codfish, was used to prevent or treat acute respiratory syndrome [<xref rid="B24-molecules-26-00632" ref-type="bibr">24</xref>]. Vitamin D is well-known to play an essential role in the maintenance of bone health and to regulate calcium-phosphorus metabolism [<xref rid="B23-molecules-26-00632" ref-type="bibr">23</xref>]. Moreover, this vitamin is also responsible for the modulation of the immune response in infectious and autoimmune disease [<xref rid="B25-molecules-26-00632" ref-type="bibr">25</xref>,<xref rid="B26-molecules-26-00632" ref-type="bibr">26</xref>]. In particular, the active form of vitamin D, <bold>calcitriol</bold> has a defined role in immune function, with anti-inflammatory activity, inhibiting the overexpression of inflammatory cytokines (e.g., IL-1&#x003b1;, IL-1&#x003b2;, TNF-&#x003b1;) (<xref ref-type="fig" rid="molecules-26-00632-f001">Figure 1</xref>) [<xref rid="B27-molecules-26-00632" ref-type="bibr">27</xref>].</p><p>Therefore, researchers have hypothesised a potential link between this compound and SARS-CoV-2, and vitamin D underwent several studies for evaluating its activity against COVID-19 [<xref rid="B28-molecules-26-00632" ref-type="bibr">28</xref>].</p><p>A possible mechanism of action was attributed to the binding between the active form of vitamin D and S protein of SARS-CoV-2. Docking results showed that calcitriol recognised the Receptor Binding Domain (RBD) of Spike glycoprotein with good binding affinity, thus engaging hydrogen bonds with Gln493 residue and hydrophobic interactions with Ser494, Tyr449, Asn450, Leu452, Tyr489, Leu492, and Glu484 residues [<xref rid="B29-molecules-26-00632" ref-type="bibr">29</xref>]. According to Weir et al., who recently reviewed vitamin D activities in the COVID-19 context, its supplement would offer an easy option in fighting against SARS-CoV-2 [<xref rid="B30-molecules-26-00632" ref-type="bibr">30</xref>]. Indeed, the authors provided several reports demonstrating that low levels of vitamin D are associated with increased inflammatory cytokines, which contribute to worsening COVID-19 severity [<xref rid="B30-molecules-26-00632" ref-type="bibr">30</xref>]. These reports raise the possibility that adequate vitamin D levels can reduce the severity of the cytokine storm, which can occur in COVID-19.</p><p>Interestingly, <italic>Jain</italic> and co-authors analysed the vitamin D level in both asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers (IL-6; TNF-&#x003b1;, and serum ferritin) [<xref rid="B31-molecules-26-00632" ref-type="bibr">31</xref>]. Vitamin D deficiency and serum level of inflammatory markers were higher in the patients with severe COVID-19 symptoms. Moreover, a positive correlation was found between the fatal rate and vitamin D deficiency [<xref rid="B31-molecules-26-00632" ref-type="bibr">31</xref>]. Despite this evidence, which encourages a mass administration of vitamin D supplements to populations at risk of COVID-19, the study suffers some drawbacks. The current analysis has been conducted in a single centre located in India, an area with a high prevalence of vitamin D deficiency. It does not consider comorbidities, such as diabetes and hypertension [<xref rid="B31-molecules-26-00632" ref-type="bibr">31</xref>].</p><p>Therefore, keeping these results in mind, a well-drawn multicentre study should be conducted to generate more robust conclusions. In general, retrospective studies demonstrated a direct link between vitamin D and COVID-19 cases and outcomes.</p><p>On the other hand, additional data did not prove this correlation [<xref rid="B32-molecules-26-00632" ref-type="bibr">32</xref>,<xref rid="B33-molecules-26-00632" ref-type="bibr">33</xref>,<xref rid="B34-molecules-26-00632" ref-type="bibr">34</xref>]. Randomized-double-blind, large-scale, well-built studies are necessary to clarify the efficacy of vitamin D for SARS-CoV-2. As far as our knowledge goes on, no conclusive evidence underwent from clinical trials (<uri xlink:href="www.clinicaltrials.gov">www.clinicaltrials.gov</uri>).</p></sec><sec id="sec2dot1dot2-molecules-26-00632"><title>2.1.2. Vitamin C</title><p><bold>Vitamin C</bold>, known as ascorbic acid, is an essential vitamin principally abundant in the <italic>Citrus spp.</italic> and commonly sold as a dietary supplement (<xref ref-type="fig" rid="molecules-26-00632-f002">Figure 2</xref>) [<xref rid="B35-molecules-26-00632" ref-type="bibr">35</xref>]. Nowadays, it is under investigation for its biological effects for COVID-19 patients [<xref rid="B36-molecules-26-00632" ref-type="bibr">36</xref>]. It has well-established antioxidant properties by scavenging oxygen free radicals and represents a key cofactor for the production of several neurotransmitters and hormones.</p><p>Vitamin C supports several cellular functions of both innate and adaptive immune systems [<xref rid="B37-molecules-26-00632" ref-type="bibr">37</xref>,<xref rid="B38-molecules-26-00632" ref-type="bibr">38</xref>]. Furthermore, upcoming studies demonstrated its anti-inflammatory properties, being able to inhibit pro-inflammatory mediators production, including IL-6, TNF-&#x003b1;, and the granulocyte-macrophage colony-stimulating factor (GM-CSF) signalling responses [<xref rid="B39-molecules-26-00632" ref-type="bibr">39</xref>]. Altogether, the biological effects shown by vitamin C may help to inhibit the &#x0201c;cytokine storm&#x0201d; observed in the SARS-CoV-2 patients and to improve the host&#x02019;s immunity. A meta-analysis of 29 clinical trials reported that vitamin C decreased the duration of the common cold by 8% in adults and 14% in children [<xref rid="B40-molecules-26-00632" ref-type="bibr">40</xref>]. Furthermore, vitamin C ameliorated upper respiratory tract infections. However, its supplementation did not prevent the incidence of colds, indicating that a regular assumption is not justified [<xref rid="B40-molecules-26-00632" ref-type="bibr">40</xref>].</p><p>Besides, the same authors reported in a meta-analysis of 12 clinical trials that vitamin C reduces the length of the intensive care unit stay by 7.8% and the duration of mechanical aided ventilation [<xref rid="B41-molecules-26-00632" ref-type="bibr">41</xref>,<xref rid="B42-molecules-26-00632" ref-type="bibr">42</xref>,<xref rid="B43-molecules-26-00632" ref-type="bibr">43</xref>]. Emerging evidence, carried out on a small clinical trial with 54 critical COVID-19 patients, demonstrated that high dose vitamin C infusion decreased the IL-6 level, concluding that this therapeutical regimen may provide a protective clinical effect without any adverse events in critical COVID-19 patients [<xref rid="B44-molecules-26-00632" ref-type="bibr">44</xref>]. Other outcomes were considered in the same clinical trial, including organ failure score, intensive care unit length, and mortality. According to the authors, a significant decrease in intensive care unit stay and hospital mortality was observed in the vitamin C treated patients [<xref rid="B44-molecules-26-00632" ref-type="bibr">44</xref>]. Overall, vitamin C seemed to possess relevant pharmacological properties against severe respiratory infections, including COVID-19 [<xref rid="B45-molecules-26-00632" ref-type="bibr">45</xref>,<xref rid="B46-molecules-26-00632" ref-type="bibr">46</xref>]. Several clinical trials, assessing the efficacy of high dose vitamin C infusion, are still ongoing and will provide more definitive evidence.</p></sec><sec id="sec2dot1dot3-molecules-26-00632"><title>2.1.3. Lactoferrin</title><p><bold>Lactoferrin (LF)</bold>, or lactotransferrin, is a cationic glycoprotein constituted by 691 aminoacids folded into two globular lobes (80 kDa), connected by an &#x003b1;-helix. LF can reversibly chelate two Fe<sup>3+</sup> cations per molecule (<xref ref-type="fig" rid="molecules-26-00632-f003">Figure 3</xref>) [<xref rid="B47-molecules-26-00632" ref-type="bibr">47</xref>,<xref rid="B48-molecules-26-00632" ref-type="bibr">48</xref>,<xref rid="B49-molecules-26-00632" ref-type="bibr">49</xref>].</p><p>This protein is mainly produced by the mammalian gland, particularly in mammalian and animal milk [<xref rid="B51-molecules-26-00632" ref-type="bibr">51</xref>]. When needed, LF may also be taken as a supplement, acting as a nutraceutical or functional food [<xref rid="B52-molecules-26-00632" ref-type="bibr">52</xref>].</p><p>Due to its iron-binding capabilities, this protein regulates the iron homeostasis in the body and does not release iron even at pH 3.5 [<xref rid="B53-molecules-26-00632" ref-type="bibr">53</xref>]. This property ensures iron sequestering in infected body compartments, where the pH is normally acidic, decreasing the availability of essential iron to microbes [<xref rid="B53-molecules-26-00632" ref-type="bibr">53</xref>]. LF exert immune-modulatory effects by increasing the expression ability of B cells and by regulating the function of T cells [<xref rid="B54-molecules-26-00632" ref-type="bibr">54</xref>]. Further, it is reported that LF has anti-inflammatory properties. This protein can access inside host cells and shift in the nucleus, thus regulating pro-inflammatory gene expression [<xref rid="B54-molecules-26-00632" ref-type="bibr">54</xref>,<xref rid="B55-molecules-26-00632" ref-type="bibr">55</xref>]. As an example, the down-regulation of IL-6 has been demonstrated in both in-vitro and in-vivo models [<xref rid="B56-molecules-26-00632" ref-type="bibr">56</xref>,<xref rid="B57-molecules-26-00632" ref-type="bibr">57</xref>].</p><p>LF is active against broad-spectrum viruses, including coronavirus [<xref rid="B58-molecules-26-00632" ref-type="bibr">58</xref>,<xref rid="B59-molecules-26-00632" ref-type="bibr">59</xref>]. It is believed that glycoprotein interacts with heparan sulfate proteoglycans of the host cells, preventing the entry of viral particles into host cells [<xref rid="B60-molecules-26-00632" ref-type="bibr">60</xref>]. Therefore, LF has received the attention of the scientific community in the prevention of SARS-CoV-2 infection. Exploring the possible mechanisms of action involving LF, a computational investigation suggested its possible effect in the early stages of the infection. Indeed, by 2D-Zernike descriptors of molecular surfaces of sialic acid receptors on the host cell membrane, ACE2, S, M, and E proteins, it was highlighted that LF could affect the viral attachment to the host cell due to its probable competition with the virus in the binding to sialic acid [<xref rid="B61-molecules-26-00632" ref-type="bibr">61</xref>,<xref rid="B62-molecules-26-00632" ref-type="bibr">62</xref>,<xref rid="B63-molecules-26-00632" ref-type="bibr">63</xref>,<xref rid="B64-molecules-26-00632" ref-type="bibr">64</xref>]. Additionally, potential competition between ACE2 and LF in the binding site of SARS-CoV-2 Spike was suggested. This is probably due to two high complementarity regions in the <italic>N-</italic> and <italic>C-</italic> terminal domains of the Spike protein to LF [<xref rid="B65-molecules-26-00632" ref-type="bibr">65</xref>].</p><p>Additional computational study sustained the idea of direct LF binding to the Spike S glycoprotein CDT1 domain, reducing the virus&#x02019;s likelihood of entering cells. Moreover, after evaluating the human LF-Spike complex, it was observed that only two residues (Thr500 and Tyr505) are involved in the interface recognition [<xref rid="B66-molecules-26-00632" ref-type="bibr">66</xref>].</p><p>From February 2020, the LF efficacy against SARS-CoV-2 has been reviewed since this protein showed promising antiviral and anti-inflammatory properties reducing the typical &#x0201c;cytokine storm&#x0201d; in COVID-19 patients [<xref rid="B52-molecules-26-00632" ref-type="bibr">52</xref>,<xref rid="B67-molecules-26-00632" ref-type="bibr">67</xref>,<xref rid="B68-molecules-26-00632" ref-type="bibr">68</xref>]. Based on the encouraging preliminary results, several clinical trials have been registered but, the only clinical trial concluded was the one of Campione et al. [<xref rid="B67-molecules-26-00632" ref-type="bibr">67</xref>]. According to the authors, LF might be used in asymptomatic or mildly symptomatic patients to prevent the worsening of SARS-CoV-2. However, despite the courageous preliminary results, more adequate and well-drawn clinical trials should be carried out to evaluate the useful, beneficial properties of LF for COVID-19 disease.</p></sec><sec id="sec2dot1dot4-molecules-26-00632"><title>2.1.4. Quercetin</title><p><bold>Quercetin</bold> is a flavonol abundantly present in vegetables and fruits (<xref ref-type="fig" rid="molecules-26-00632-f004">Figure 4</xref>) [<xref rid="B10-molecules-26-00632" ref-type="bibr">10</xref>].</p><p>This compound gained attention for its pharmacological properties, such as antiviral, anti-inflammatory, pro-metabolic and anticancer [<xref rid="B10-molecules-26-00632" ref-type="bibr">10</xref>,<xref rid="B69-molecules-26-00632" ref-type="bibr">69</xref>,<xref rid="B70-molecules-26-00632" ref-type="bibr">70</xref>]. In light of this, quercetin was studied against COVID-19 as well.</p><p>In particular, the capability of quercetin to inhibit the proteases of SARS-CoV-2 was discussed. Regarding SARS-CoV-2 Mpro, docking studies highlighted quercetin as able to accommodate into this target binding site, establishing hydrogen bonds with Asn142, Ser144, and Met165. Also, hydrophobic contacts were established with Met49, Phe140, Leu141, and electrostatic interactions were engaged with His164 and Glu166 residues. The likelihood to interfere in the proteolytic activity of Mpro could be attributed to the destabilizing effect of quercetin into the catalytic pocket. It occurs due to its ability to adopt multiple binding poses, resulting in a favourable entropy gain. Strong experimental evidence validated this theoretical hypothesis [<xref rid="B71-molecules-26-00632" ref-type="bibr">71</xref>]. Concerning the SARS-CoV-2 papain-like protease (PLpro), quercetin did not result as a good binder in a theoretical study [<xref rid="B72-molecules-26-00632" ref-type="bibr">72</xref>]. Conversely, a computational investigation evidenced it as able to bind at S protein: ACE2 receptor interface [<xref rid="B73-molecules-26-00632" ref-type="bibr">73</xref>]. In vitro studies demonstrated that quercetin inhibited recombinant human (rh) ACE2 activity [<xref rid="B74-molecules-26-00632" ref-type="bibr">74</xref>,<xref rid="B75-molecules-26-00632" ref-type="bibr">75</xref>]. More recently, the clinical trials (NCT04468139 and NCT04377789) including quercetin, were involved in both prophylaxis and treatment of COVID-19 [<xref rid="B76-molecules-26-00632" ref-type="bibr">76</xref>,<xref rid="B77-molecules-26-00632" ref-type="bibr">77</xref>,<xref rid="B78-molecules-26-00632" ref-type="bibr">78</xref>].</p></sec><sec id="sec2dot1dot5-molecules-26-00632"><title>2.1.5. Resveratrol</title><p><bold>Resveratrol</bold> is the most extensively studied stilbene natural compound (<xref ref-type="fig" rid="molecules-26-00632-f005">Figure 5</xref>). Stilbenoids are phenolic molecules and due to their biosynthesis by the plants after ultraviolet radiation, toxins and injures, are also classified as phytoalexins. Chemically, stilbenoids show a common backbone including different types and position and substituents groups on the aromatic rings.</p><p>This kind of natural compound is endowed with numerous biological activities; therefore, recent studies focused on possible resveratrol effect against COVID-19 [<xref rid="B17-molecules-26-00632" ref-type="bibr">17</xref>,<xref rid="B79-molecules-26-00632" ref-type="bibr">79</xref>]. Computational analysis showed its good binding property towards SARS-CoV-2 Spike protein and human ACE2 receptor interface.</p><p>Docking results highlighted its strong interactions with crucial residues involved in the binding between S protein of SARS-CoV-2 and ACE2 receptor, establishing two hydrogen bonds with Lys353 of S protein and Gly496 of ACE2 receptor. The structural stability of resveratrol at its interface binding pose was confirmed by molecular dynamic simulations [<xref rid="B80-molecules-26-00632" ref-type="bibr">80</xref>]. Furthermore, an in-vitro study reported a dose-dependent antiviral effect of resveratrol on SARS-CoV-2 infection in Vero E6 cells [<xref rid="B81-molecules-26-00632" ref-type="bibr">81</xref>]. Currently, several clinical trials for resveratrol are undergoing (NCT04542993, NCT04536090, and NCT04377789).</p></sec><sec id="sec2dot1dot6-molecules-26-00632"><title>2.1.6. Hanfangchin A</title><p>According to Riva et al., <bold>hanfangchin A</bold>, also called tetrandrine (TET) (<xref ref-type="fig" rid="molecules-26-00632-f006">Figure 6</xref>), showed dose-dependent antiviral activities [<xref rid="B82-molecules-26-00632" ref-type="bibr">82</xref>,<xref rid="B83-molecules-26-00632" ref-type="bibr">83</xref>]. TET is a benzyltetrahydroisoquinoline alkaloid isolated from the root of the plant <italic>Stephania tetrandra</italic> with several pharmacological effects [<xref rid="B84-molecules-26-00632" ref-type="bibr">84</xref>]. Structurally, two benzyl-tetrahydroisoquinolines are connected to ether linkages to form tetrandrine with tetrahydroisoquinoline <italic>N</italic>-methylation, bearing an irregular eighteen-member ring [<xref rid="B85-molecules-26-00632" ref-type="bibr">85</xref>].</p><p>It was hypothesized that TET could work by blocking the two-pore channel 2 (TPC2) located in the membranes of host endolysosomal compartments by which SARS-CoV-2 can egress from these organelles and continue its replication [<xref rid="B83-molecules-26-00632" ref-type="bibr">83</xref>,<xref rid="B85-molecules-26-00632" ref-type="bibr">85</xref>].</p><p>TET was excluded by in silico studies because it violated three drug-likeness properties reported in Lipinski&#x02019;s Rule of 5. In detail, it showed a LogP value of 6.4, and the increase of lipophilicity property can result in a probable lack of selectivity and attrition in drug development [<xref rid="B86-molecules-26-00632" ref-type="bibr">86</xref>]. For this, further investigations are needed [<xref rid="B87-molecules-26-00632" ref-type="bibr">87</xref>]. The promising pharmacological efficacy as anti-COVID-19 agent was demonstrated in Vero E6 (EC<sub>50</sub> = 1.2 &#x000b5;M), Huh-7 (EC<sub>50</sub> = 0.64 &#x000b5;M), and HEK293T (EC<sub>50</sub> = 0.56 &#x000b5;M) cells transduced with ACE2. Furthermore, exceptional levels of synergy with remdesivir have been reported [<xref rid="B88-molecules-26-00632" ref-type="bibr">88</xref>]. A clinical trial for TET has been designed (NCT04308317).</p></sec><sec id="sec2dot1dot7-molecules-26-00632"><title>2.1.7. Glycyrrhizin</title><p><bold>Glycyrrhizin</bold>, an active component of liquorice roots, was investigated against SARS-CoV-2 (<xref ref-type="fig" rid="molecules-26-00632-f007">Figure 7</xref>). Combining high throughput screening (HTS) and computational approaches, for terpene-based compounds, it was analyzed the likelihood of Glycyrrhizin to insert between SARS-CoV-2 RBD-ACE2 complex. In detail, it is worth noting that Glycyrrhizin recognized Asn501, Gln498, Gly496, Tyr449, Tyr453, and Glu484 by means of hydrogen bond interactions and hydrophobic contacts with Tyr489, Phe456, and Leu455 [<xref rid="B89-molecules-26-00632" ref-type="bibr">89</xref>]. Other glycyrrhizin involvements could be summarized as follows: (1) targeting S-RBD-ACE2 complex, (2) controlling pro-inflammatory cytokines, (3) preventing the accumulation of the intracellular ROS, (4) controlling thrombi, (5) preventing the fast production of airway exudates, and (6) persuading endogenous interferon against SARS-CoV-2 [<xref rid="B90-molecules-26-00632" ref-type="bibr">90</xref>]. Recently, glycyrrhizin was recruited in a clinical trial (NCT04487964).</p></sec><sec id="sec2dot1dot8-molecules-26-00632"><title>2.1.8. Artemisinin</title><p>The anti-SARS-CoV-2 activity was also investigated for the compounds extracted from <italic>Artemisia Annua</italic>. Among these, <bold>artemisinin</bold> (<xref ref-type="fig" rid="molecules-26-00632-f008">Figure 8</xref>) the most abundant active component, is an antimalarial agent showing a promising broad-spectrum antiviral activity [<xref rid="B91-molecules-26-00632" ref-type="bibr">91</xref>,<xref rid="B92-molecules-26-00632" ref-type="bibr">92</xref>]. In-silico approaches helped to understand the possible mechanism of artemisinin to prevent the interaction between S protein and ACE2 receptor, due to its ability to bind Lys353 and Lys31 hotspot binding region [<xref rid="B93-molecules-26-00632" ref-type="bibr">93</xref>].</p><p>To date, we have in-vitro evidence for artemisinin and its derivative arteannuin B, and a clinical trial is undergoing (NCT04382040) [<xref rid="B93-molecules-26-00632" ref-type="bibr">93</xref>,<xref rid="B94-molecules-26-00632" ref-type="bibr">94</xref>].</p></sec><sec id="sec2dot1dot9-molecules-26-00632"><title>2.1.9. Colchicine</title><p><bold>Colchicine</bold> (<xref ref-type="fig" rid="molecules-26-00632-f009">Figure 9</xref>) extracted from the <italic>Colchicum autumnale</italic> is used for the treatment and management of patients with gout. In recent years, this old drug was also proposed in a variety of illnesses, including rheumatic and cardiovascular diseases [<xref rid="B95-molecules-26-00632" ref-type="bibr">95</xref>].</p><p>The possible role of colchicine was hypothesized <italic>versus</italic> COVID-19 infection. Ito et al. highlighted how SARS-CoV and its accessory protein could activate pro-IL-1&#x003b2; gene transcription and protein maturation, and subsequently, NLRP3 inflammasome [<xref rid="B96-molecules-26-00632" ref-type="bibr">96</xref>]. Indeed, the anti-inflammatory activity of colchicine mainly depends on the inhibition of the NLRP3 inflammasome [<xref rid="B97-molecules-26-00632" ref-type="bibr">97</xref>]. Other anti-COVID-19 mechanism have been proposed [<xref rid="B98-molecules-26-00632" ref-type="bibr">98</xref>].</p><p>Therefore, this compound could be utilized for the treatment of COVID-19. To date, several clinical trials are undergoing (NCT04527562, NCT04392141, NCT04375202, NCT04355143, and NCT04360980).</p><p>Scarsi et al., report a 20% improvement in the survival rate at 21 days in patients treated with colchicine compared with the local standard of care [<xref rid="B99-molecules-26-00632" ref-type="bibr">99</xref>]. However, Gendelman and co-authors did not detect a potential benefit of colchicine for COVID-19 treatment [<xref rid="B100-molecules-26-00632" ref-type="bibr">100</xref>].</p></sec><sec id="sec2dot1dot10-molecules-26-00632"><title>2.1.10. Berberine</title><p><bold>Berberine</bold> (<xref ref-type="fig" rid="molecules-26-00632-f010">Figure 10</xref>) is an alkaloid extracted from <italic>Berberis vulgaris</italic> L. which was extensively studied for its pharmacological activities with applications in several therapeutic areas, including cancer [<xref rid="B101-molecules-26-00632" ref-type="bibr">101</xref>,<xref rid="B102-molecules-26-00632" ref-type="bibr">102</xref>,<xref rid="B103-molecules-26-00632" ref-type="bibr">103</xref>]. The antiviral activity of berberine against influenza and alphaviruses has been described [<xref rid="B104-molecules-26-00632" ref-type="bibr">104</xref>]. In the SARS-CoV-2 context, Pizzorno et al. demonstrated the in vitro efficacy against SARS-CoV-2 in Vero E6 cells [<xref rid="B105-molecules-26-00632" ref-type="bibr">105</xref>]. These findings agree with other studies [<xref rid="B106-molecules-26-00632" ref-type="bibr">106</xref>,<xref rid="B107-molecules-26-00632" ref-type="bibr">107</xref>]. An in silico study reported that berberine well-recognized the main protease by establishing hydrogen bond interactions with Phe140 and Asn142 [<xref rid="B108-molecules-26-00632" ref-type="bibr">108</xref>].</p><p>Due to its promising anti-COVID-19 activities, this compound underwent in clinical trial, but no results are available (NCT04479202).</p></sec></sec><sec id="sec2dot2-molecules-26-00632"><title>2.2. Natural Compounds with Promising Activities Against SARS-CoV-2 Infection</title><p>A few weeks later, after the outbreak of the pandemic, natural occurring compounds deriving from different chemical-diverse scaffolds showed promising data against SARS-CoV-2 druggable targets. However, as most scientific efforts provided computational studies without any experimental validation, the hope is that further in-vitro and in-vivo experiments will be performed. In this perspective, this section aims to summarize the results extrapolated by scientific literature achieved so far on the natural chemical scaffolds with promising activities against SARS-CoV-2 infection.</p><sec id="sec2dot2dot1-molecules-26-00632"><title>2.2.1. Alkaloids</title><p>Alkaloids are fundamental chemical components representing a rich natural source for exploitation in human health. Their chemical scaffolds are characterized by nitrogen-containing groups, often within heterocyclic rings. Alkaloids show various biological properties in several diseases [<xref rid="B109-molecules-26-00632" ref-type="bibr">109</xref>].</p><p>Based on the known antiviral activity of some alkaloids, a computational study was designed to investigate their effect against SARS-CoV-2 Mpro. Among them, <bold>thalimonine</bold> and <bold>sophaline</bold> well recognized the binding pocket of the protease (<xref ref-type="fig" rid="molecules-26-00632-f011">Figure 11</xref>).</p><p>Thalimonine engaged two hydrogen bonds with Cys145 and Ser144 and a &#x003c0;-cation interaction with His41. Instead, sophaline was able to form a hydrogen bond with His163 and hydrophobic contacts with His41, Met49, Gly143, Cys145, Met165, and Gln189 residues.</p><p>Computational analysis of alkaloids from <italic>Cryptolepis sanguinolenta</italic> was performed against Mpro and RNA-dependent RNA&#x02013;polymerase (RdRp), revealing that <bold>cryptomisrine</bold>, <bold>cryptospirolepine</bold>, <bold>cryptoquindoline</bold>, and <bold>biscryptolepine</bold> (<xref ref-type="fig" rid="molecules-26-00632-f012">Figure 12</xref>) exhibited robust binding affinity towards these two SARS-CoV-2 targets. Overall, all these alkaloids were able to recognize the active site of the two studied targets. Among these, for SARS-CoV-2 Mpro, <bold>cryptospirolepine</bold> well interacted with the catalytic dyad; for the polymerase, the best one was the <bold>cryptomisrine</bold> which was involved in <italic>&#x003c0;</italic>-cation interactions with Arg553 and Arg624 residues of SARS-CoV-2 RdRp [<xref rid="B110-molecules-26-00632" ref-type="bibr">110</xref>]. Gyebi et al. studied the involvement of these alkaloids in the prevention of SARS-CoV-2 cell entry. In particular, <bold>cryptospirolepine</bold> was able to form several interactions with Phe40, Ala348, Arg393, His401 in the subdomain I of ACE2. In addition to the block access to ACE2, <bold>cryptospirolepine</bold> and <bold>cryptoquindoline</bold> could inhibit the cleavage of Spike glycoprotein by interacting with TMPRSS2 [<xref rid="B111-molecules-26-00632" ref-type="bibr">111</xref>].</p><p>Also, tropane alkaloids from <italic>Schizanthus porrigens</italic> have been studied as promising inhibitors of SARS-CoV-2 PLpro. <bold>Schizanthine Z</bold> and <bold>schizanthine Y</bold> (<xref ref-type="fig" rid="molecules-26-00632-f013">Figure 13</xref>) were able to recognize the protein through the interaction with Tyr164 and Tyr173 residues; meanwhile, <bold>schizanthine Y</bold> engaged an additional hydrogen bond with Tyr168. The in-vitro experiments are highly recommended [<xref rid="B112-molecules-26-00632" ref-type="bibr">112</xref>].</p><p>Among the alkaloids from <italic>Justicia adhatoda</italic>, <bold>anisotine</bold> (<xref ref-type="fig" rid="molecules-26-00632-f014">Figure 14</xref>a) could have promising inhibitory activity against SARS-CoV-2 Mpro due to its interaction with the key catalytic residues (His41 and Cys145) of the Mpro pocket using computational approach [<xref rid="B113-molecules-26-00632" ref-type="bibr">113</xref>].</p><p>Quimque et al. virtually screened the fungal natural products against PLpro and Mpro, RdRp, nsp15, and the Spike binding domain to glucose-regulated protein 78 (GRP78). It was resulted that two fumiquinazoline alkaloids <bold>quinadoline B</bold> and <bold>scedapin C</bold> (<xref ref-type="fig" rid="molecules-26-00632-f014">Figure 14</xref>b,c) had strong in silico inhibitory activity towards the analyzed SARS-CoV-2 targets [<xref rid="B114-molecules-26-00632" ref-type="bibr">114</xref>].</p></sec><sec id="sec2dot2dot2-molecules-26-00632"><title>2.2.2. Terpenes</title><p>Recently, the involvement of plant-based terpenes was also noticed for COVID-19 infection [<xref rid="B115-molecules-26-00632" ref-type="bibr">115</xref>,<xref rid="B116-molecules-26-00632" ref-type="bibr">116</xref>]. Chemically, they are formed by multiple isoprene units (C5) and based on their number they are classified as hemi-, mono-, sesqui-, di-, tri-, tetra-, and polyterpenes. This class of chemical compounds along with their derivatives, terpenoids, which contains steroids/sterols, saponines and meroterpenes, offer an extensive range of applications in human health [<xref rid="B117-molecules-26-00632" ref-type="bibr">117</xref>,<xref rid="B118-molecules-26-00632" ref-type="bibr">118</xref>].</p><p>Recent investigations reported that <bold>citronellol</bold>, <bold>geraniol</bold>, <bold>limonene</bold>, <bold>linalool</bold>, and <bold>neryl acetate</bold> contained in the geranium and lemon essential oils down-regulated ACE2 receptor activity in virus-host epithelial cells [<xref rid="B119-molecules-26-00632" ref-type="bibr">119</xref>]. Kulkarni et al. evaluated the major components of plant essential oils such as <bold>anethole</bold>, <bold>cinnamaldehyde</bold>, <bold>carvacrol</bold>, <bold>geraniol</bold>, <bold>cinnamyl acetate</bold>, <bold><sc>l</sc>-4-terpineol</bold>, <bold>thymol,</bold> and <bold>pulegone</bold> as promising inhibitors of SARS-CoV-2 Spike protein by in-silico approach [<xref rid="B120-molecules-26-00632" ref-type="bibr">120</xref>].</p><p>Among terpenoid derivatives, by molecular docking simulation, it was revealed that <bold>limonin</bold> and <bold>scopadulcic acid B</bold> showed a good binding affinity towards RdRp, Spike protein, and ACE2 receptor [<xref rid="B119-molecules-26-00632" ref-type="bibr">119</xref>,<xref rid="B121-molecules-26-00632" ref-type="bibr">121</xref>].</p><p>Carino et al. identified several triterpenoids and steroidal molecules (<xref ref-type="fig" rid="molecules-26-00632-f015">Figure 15</xref>) as inhibitors of Spike-ACE2 interactions [<xref rid="B122-molecules-26-00632" ref-type="bibr">122</xref>]. In details, these studies reported that <bold>glycyrrhetinic acid</bold> (<xref ref-type="fig" rid="molecules-26-00632-f015">Figure 15</xref>a), <bold>betulinic acid</bold> (<xref ref-type="fig" rid="molecules-26-00632-f015">Figure 15</xref>b), and <bold>oleanolic acid</bold> (<xref ref-type="fig" rid="molecules-26-00632-f015">Figure 15</xref>d), were able to well recognize the RBD&#x02019;s pocket 1. Docking results underlined that the steroidal scaffold could interact with Trp436, Phe374, Arg509, and Leu441 residues of the hydrophobic pocket of RBD. In addition, glycyrrhetinic acid engaged hydrogen bonds with Asn440, Ser375 and ionic contacts with Arg509.</p><p>The experimental results found that the incubation of the Spike-ACE2 complex with these naturally occurring triterpenoids reduced the Spike-ACE2 binding in a concentration-dependent way. Among all the compounds mentioned, <bold>betulinic and oleanolic acid</bold> showed significant inhibition at a concentration of 0.1 &#x000b5;M and 10 &#x000b5;M, respectively [<xref rid="B122-molecules-26-00632" ref-type="bibr">122</xref>]. Interestingly, the pre-incubation of oleanolic and glycyrrhetinic acid with Spike-ACE2 complex exhibited a more remarkable ability to reduce the interaction between them and biological targets [<xref rid="B122-molecules-26-00632" ref-type="bibr">122</xref>].</p><p>In-silico study revealed that <bold>betulinic acid</bold> and <bold>glycyrrhetinic acid</bold> (triterpene derivatives) showed good binding energies against the protease SARS-CoV-2. In detail, these compounds could recognize the Mpro structure pocket forming an hydrogen bonds with Lys137 and hydrophobic contacts with Tyr237, Tyr239, Leu272, Leu286, and Leu287 [<xref rid="B123-molecules-26-00632" ref-type="bibr">123</xref>].</p><p>Based on the structural similarity between <bold>oleanolic acid</bold> and <bold>ursolic acid</bold> (<xref ref-type="fig" rid="molecules-26-00632-f015">Figure 15</xref>c,d)<bold>,</bold> and due to their comparable pharmacological activities, the possible binding mode of these compounds towards the catalytic pocket of SARS-CoV-2 Mpro was analyzed. Thus, it was observed that <bold>ursolic acid</bold> formed a hydrogen bond with Ser46 and several Van der Waals interactions with Thr24, Thr25, Thr26, Cys44, Thr45, Asn142, Gly143, Cys145, and Glu166 residues of the protease. Further, in silico results showed that <bold>oleanolic acid</bold> was involved with the catalytic dyad of the SARS-CoV-2 protease establishing both a hydrogen bond and several hydrophobic contacts with Gln189, Cys145 and His163 residues, respectively [<xref rid="B124-molecules-26-00632" ref-type="bibr">124</xref>].</p><p>According to the idea that these triterpenoids are the natural substrates for two bile acid receptors such as Farnesoid-X-Receptor (FXR) and G-protein Bile Acid Receptor (GPBAR)-1, the behaviour of some natural <bold>bile acids</bold> (<xref ref-type="fig" rid="molecules-26-00632-f016">Figure 16</xref>) were also investigated against SARS-CoV-2 druggable targets. The analyzed steroidal compounds were able to fit into pocket 5 on the surface of the &#x003b2;-sheet core of Spike RBD. In detail, the steroidal scaffold of the <bold>ursodeoxycholic acid</bold> (<xref ref-type="fig" rid="molecules-26-00632-f016">Figure 16</xref>b) is surrounded by Lys378, Thr376, Phe377, Tyr380, and Pro384 and formed a hydrogen bond with Cys379 [<xref rid="B122-molecules-26-00632" ref-type="bibr">122</xref>]. The in vitro screening confirmed that the <bold>ursodeoxycholic acid</bold> and its taurine conjugate exerted a limited inhibitory activity towards Spike-ACE2 complex. In contrast, <bold>glyco-ursodeoxycholic acid</bold> (<xref ref-type="fig" rid="molecules-26-00632-f016">Figure 16</xref>c)<bold>, chenodeoxycholic acid</bold> (<xref ref-type="fig" rid="molecules-26-00632-f016">Figure 16</xref>a)<bold>,</bold> and <bold>glyco-chenodeoxycholic acid</bold> (<xref ref-type="fig" rid="molecules-26-00632-f016">Figure 16</xref>d) reduce the Spike binding to the ACE2 receptor by at least 20% in a concentration-dependent manner. Despite these promising in-vitro results, the studies have several limitations; e.g., the effects of these natural molecules were not tested on viral replication [<xref rid="B122-molecules-26-00632" ref-type="bibr">122</xref>].</p><p>In addition to the activity against ACE2, the binding affinity of triterpene derivatives and steroid-based compounds against SARS-CoV-2 Mpro was explored. The <bold>ursodeoxycholic acid</bold> formed two hydrogen bonds with Phe140 and Ser46 residues, while Met49, Met165, Cys145, and Leu141 residues participated in hydrophobic interactions that enhanced stability of the protein-ligand complex. These in silico results showed that ursodeoxycholic acid had potential viral inhibitory activity towards SARS-CoV-2 Mpro and human ACE2 protein, but further experimental validations are needed to confirm their biological activity [<xref rid="B125-molecules-26-00632" ref-type="bibr">125</xref>].</p><p>Additionally, several natural constituents of <italic>Withania somnifera</italic>, also known as Ashwagandha and &#x0201c;Indian Ginseng&#x0201d;, were explored as possible inhibitors of Mpro SARS-CoV-2 protease. From the study, <bold>withanoside V</bold> (<xref ref-type="fig" rid="molecules-26-00632-f016">Figure 16</xref>i), a steroid-based compound, was the most potent natural inhibitor [<xref rid="B126-molecules-26-00632" ref-type="bibr">126</xref>].</p><p>Others phytoconstituents from <italic>Withania somnifera</italic> such as <bold>quercetin-3-<italic>O</italic>-galactosyl-rhamnosyl-glucoside</bold> (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>l), <bold>withanoside X</bold> (<xref ref-type="fig" rid="molecules-26-00632-f016">Figure 16</xref>h), <bold>ashwagandhanolide</bold> (<xref ref-type="fig" rid="molecules-26-00632-f016">Figure 16</xref>g), <bold>dihydrowithaferin A</bold> (<xref ref-type="fig" rid="molecules-26-00632-f016">Figure 16</xref>f) and <bold>withanolide N</bold> (<xref ref-type="fig" rid="molecules-26-00632-f016">Figure 16</xref>e) were investigated as promising inhibitors of Spike glycoprotein and Nsp15 endoribonuclease [<xref rid="B127-molecules-26-00632" ref-type="bibr">127</xref>].</p><p>Among phytoconstituents from <italic>Nigella sativa</italic>, <bold>campesterol</bold>, <bold>cycloeucalenol</bold>, <bold>apha-spinasterol,</bold> and <bold>beta-sitosterol</bold> showed strong affinities against viral N-terminal RNA binding domain (NRBD) and PLpro of SARS-CoV-2 [<xref rid="B128-molecules-26-00632" ref-type="bibr">128</xref>].</p></sec><sec id="sec2dot2dot3-molecules-26-00632"><title>2.2.3. Flavonoids</title><p>Among the naturally occurring compounds and beyond, flavonoids (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>) are particularly studied [<xref rid="B129-molecules-26-00632" ref-type="bibr">129</xref>], including their role versus SARS-CoV-2 [<xref rid="B130-molecules-26-00632" ref-type="bibr">130</xref>]. Many in-silico screenings of medicinal plant databases against SARS-CoV-2 druggable targets have been carried out [<xref rid="B131-molecules-26-00632" ref-type="bibr">131</xref>,<xref rid="B132-molecules-26-00632" ref-type="bibr">132</xref>]. Indeed, analyzing the potential role of the flavonoids against SARS-CoV-2 main protease [<xref rid="B133-molecules-26-00632" ref-type="bibr">133</xref>], it was noticed that their inhibitory activity was more extensive than that of the peptide-derived inhibitors [<xref rid="B134-molecules-26-00632" ref-type="bibr">134</xref>]. Starting from this <italic>rationale</italic>, a thorough investigation was focused on the common pharmacophoric features of flavonoids.</p><p>The presence of two phenyl groups could be responsible for inhibiting the proteolytic activity of SARS-CoV-2 protease. In particular, by analyzing docking and molecular dynamics results, the hydrogen bond between the hydroxyl group of phenyl moiety of <bold>kaempferol</bold> (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>e) and Glu166 was formed; meanwhile, the chromen-4-one scaffold was able to accommodate into the hydrophobic site. Additionally, the complex was further stabilized by two hydrogen bonds between the hydroxyl groups and Ile188 and Asp142 [<xref rid="B134-molecules-26-00632" ref-type="bibr">134</xref>,<xref rid="B135-molecules-26-00632" ref-type="bibr">135</xref>].</p><p>Again, <bold>quercetin-3-&#x003b2;-galactoside</bold> (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>p) a flavonoid-based compound, was found to bind SARS-CoV-2 Mpro through numerous interactions with the key residues of the catalytic pocket. Notably, the <italic>N</italic> atom of the main chain of Glu166 made two hydrogen bonds with the compound, while the Gln189 side chain was able to form other four similar interactions. The hydrophobic contacts between the compound and Leu141, Asn142, Met165, and Glu166 residues were evident too. Concentrating on their chemical scaffold, it is possible to rationalize that: (1) four hydroxyl groups of quercetin are crucial determinants of the bioactivity of this type of compounds; (2) the shape of sugar moiety and 7-hydroxy site of quercetin can be characterized by large structural modifications in order to enhance the binding interactions [<xref rid="B136-molecules-26-00632" ref-type="bibr">136</xref>].</p><p>Other examples were represented by the computational analysis performed on <bold>baicalin</bold> (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>q), <bold>herbacetin</bold> (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>f), and <bold>pectolinarin</bold> (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>r) towards SARS-CoV-2 Mpro. Therefore, herbacetin showed the same kaempferol binding mode. Pectolinarin showed its <sc>l</sc>-mannopyranosyl-&#x003b2;-<sc>d</sc>-glucopyranoside moiety accommodated into the S1 and S2 sites and the chromen-4-one scaffold located within the S2 and S3&#x02019; SARS-CoV Mpro domains. The baicalin glucuronate moiety interacted through two hydrogen bonds with Gly143 and Asn142 residues. In addition, the <italic>&#x003c0;-&#x003c0;</italic> stacking between His41 and its phenyl moiety was observed. In this case, Glu166 plays a pivotal role in the binding mode due to its interaction with the 6-hydroxyl group attached to the chromen-4-one moiety and the 5-hydroxyl group attached to the glucuronate moiety. Baicalin, herbacetin, and pectolinarin revealed the prominent inhibitory activity against SARS-CoV-2 Mpro. Indeed, the experimental IC<sub>50</sub> values were 34.71, 53.90, and 51.64 &#x000b5;M, respectively [<xref rid="B135-molecules-26-00632" ref-type="bibr">135</xref>].</p><p>In-silico study reported that <bold>broussoflavonol F</bold> (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>a) could better recognize SARS-CoV-2 Mpro active site due to the interaction with the catalytic dyad Cys145 and His41 [<xref rid="B137-molecules-26-00632" ref-type="bibr">137</xref>].</p><p>In addition to the estimated binding affinity towards the protease, flavonoids have also shown promising ACE2 inhibitory activities [<xref rid="B138-molecules-26-00632" ref-type="bibr">138</xref>]. A study highlighted that <bold>quercetin</bold> (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>d), <bold>myricetin</bold> (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>b), <bold>hesperetin</bold> (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>c), <bold>tricetin</bold> (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>g), and <bold>rutin</bold> (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>m) presented stable binding affinity against Spike-ACE2 protein [<xref rid="B132-molecules-26-00632" ref-type="bibr">132</xref>]. It was suggested that these compounds formed interactions with Arg273, Thr371, His345, Pro346, Glu375, Glu402, and Tyr515 in the ACE2 binding site. With this in mind, it was hypothesized that these natural compounds could compete with the bind of SARS-CoV-2 to ACE2, thus preventing the virus entry into host cells [<xref rid="B139-molecules-26-00632" ref-type="bibr">139</xref>,<xref rid="B140-molecules-26-00632" ref-type="bibr">140</xref>].</p><p>Furthermore, other research team noticed that, in addition to the above-mentioned flavonoids, <bold>nobiletin</bold> (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>h), <bold>naringenin</bold> (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>i), <bold>neohesperidin</bold> (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>n), and <bold>scutellarin</bold> (<xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>o), were also able to interact with the Spike-ACE2 complex [<xref rid="B138-molecules-26-00632" ref-type="bibr">138</xref>]. However, their IC<sub>50</sub> values were not still calculated. Despite the encouraging results of these natural compounds, in vitro steps were halted. Some drawbacks probably related to the extraction of these compounds from plants or the chemical synthesis difficulties did not permit further biological investigations. Recently, in-vitro study revealed that neohesperidin could inhibit infected Vero E6 cell [<xref rid="B141-molecules-26-00632" ref-type="bibr">141</xref>].</p><p>Baicalin interacted at the interface between ACE2 receptor and Spike protein through Asp67, Ala71, Lys74, and Asn448, Ala464, Val472 and Gly474 residues, respectively. These in silico results were validated by in vitro experiments, having an IC<sub>50</sub> around 2.24 &#x000b5;M on inhibiting the Spike protein and ACE2 receptor binding [<xref rid="B138-molecules-26-00632" ref-type="bibr">138</xref>].</p></sec><sec id="sec2dot2dot4-molecules-26-00632"><title>2.2.4. Benzoquinones</title><p>Quinones are a fascinating class of compounds with attractive chemistry. 1,4-benzoquinones reoccurring structural motif is present in various isolated natural products, and this bestowing a broad range of biological activities [<xref rid="B142-molecules-26-00632" ref-type="bibr">142</xref>]. Additionally, their derivatives also have shown promising ACE2 inhibitory activities [<xref rid="B138-molecules-26-00632" ref-type="bibr">138</xref>].</p><p>In this regard, <bold>embelin</bold>, a naturally occurring para-benzoquinone extract from <italic>Embelia ribes</italic> plant, aroused particular interest (<xref ref-type="fig" rid="molecules-26-00632-f018">Figure 18</xref>a). This natural compound showed several pharmacological effects, and it was considered the second solid gold of India, preceded by curcumin [<xref rid="B143-molecules-26-00632" ref-type="bibr">143</xref>,<xref rid="B144-molecules-26-00632" ref-type="bibr">144</xref>]. The <italic>rationale</italic> is addressable to the quinone reactivity with cysteine protease [<xref rid="B145-molecules-26-00632" ref-type="bibr">145</xref>]. Moreover, a density functional theory (DFT) computational approach highlighted the mechanism of action of embelin into SARS-CoV-2 protease. The covalent bond between the quinone carbonyl and the thiolate of Cys145 was hypothesized. To help this reaction mechanism, His41 captured the hydrogen atom from Cys145 that became prone to release a proton to the carbonyl quinone engaged with the thiolate [<xref rid="B146-molecules-26-00632" ref-type="bibr">146</xref>].</p><p>By computational methods was observed that <bold>emodin</bold> (<xref ref-type="fig" rid="molecules-26-00632-f018">Figure 18</xref>b) binds Asp67, Ala71, and Lys74 residues of ACE2 receptor, and Asn448, Ala464, Val472, and Gly474 residues of Spike protein [<xref rid="B147-molecules-26-00632" ref-type="bibr">147</xref>]. An experimental study has been shown that emodin, extracted from <italic>Rheum officinale</italic> and <italic>Reynoutria multiflora</italic>, could act as an inhibitor of the viral Spike protein and human ACE2 receptor binding with IC<sub>50</sub> value approximately of 1&#x02013;10&#x000b5;M in other SARS coronavirus [<xref rid="B148-molecules-26-00632" ref-type="bibr">148</xref>]. Thus, its promising theoretical mechanism and its known experimental activity against other coronaviruses can stimulate to investigate the potential inhibitory effect against SARS-CoV-2.</p></sec><sec id="sec2dot2dot5-molecules-26-00632"><title>2.2.5. Other Natural Compounds</title><p>In-silico studies were also performed on natural compounds that are readily available in onion, garlic, ginger, peppermint, and fenugreek [<xref rid="B149-molecules-26-00632" ref-type="bibr">149</xref>,<xref rid="B150-molecules-26-00632" ref-type="bibr">150</xref>]. The computational results pointed out <bold>leucopelargonidin</bold> and <bold>aronadendin</bold> are promising Mpro inhibitors, while <bold>5S-5-Hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-3-heptanone</bold>, contained in Ginger, interacted with the SARS-CoV-2 Spike protein [<xref rid="B111-molecules-26-00632" ref-type="bibr">111</xref>,<xref rid="B132-molecules-26-00632" ref-type="bibr">132</xref>]. This study needs appropriate biological experimental validation against COVID-19 [<xref rid="B119-molecules-26-00632" ref-type="bibr">119</xref>,<xref rid="B121-molecules-26-00632" ref-type="bibr">121</xref>].</p><p>Among phenolic compounds extracted from honey and propolis, it was observed that <bold>ellagic acid</bold> made hydrogen bonds with Gly808, Pro809, His816, thr817 and Tyr831 residues of SARS-CoV-2 RdRp. Docking results also showed that hydrogen bonds between ellagic acid and His41, Gly143, Arg188 were formed. Furthermore, Shaldam et al. proposed <bold>artepillin C</bold> as a potential inhibitor of the SARS-CoV-2 Mpro due to the interactions between the phenolic compound and Cys145, Arg188, Thr190 and Gln192 [<xref rid="B151-molecules-26-00632" ref-type="bibr">151</xref>].</p></sec></sec></sec><sec sec-type="discussion" id="sec3-molecules-26-00632"><title>3. Discussion and Future Perspectives</title><p>Since SARS-CoV-2 has become a pandemic infection with relevant health issues, the scientific community carried out much effort for the identification of potential drug targets to tackle this virus infection. Recently, several articles have been published, most of them based on the virtual screening of natural occurring compounds towards viral target proteins [<xref rid="B152-molecules-26-00632" ref-type="bibr">152</xref>,<xref rid="B153-molecules-26-00632" ref-type="bibr">153</xref>,<xref rid="B154-molecules-26-00632" ref-type="bibr">154</xref>,<xref rid="B155-molecules-26-00632" ref-type="bibr">155</xref>].</p><p>Especially in emergent diseases, such as COVID-19, computer-assisted techniques are useful tools to find out potential new drugs. By harnessing the innovative technologies in rational drug design in the medicinal chemistry field, it has been possible to obtain promising compounds fitted to recognize several targets of the other coronaviruses [<xref rid="B21-molecules-26-00632" ref-type="bibr">21</xref>,<xref rid="B156-molecules-26-00632" ref-type="bibr">156</xref>].</p><p>Several chemical entities have already been investigated by computational approaches such as docking, DFT, molecular dynamics simulations; however, no novel compounds have been proposed until now, except for repurposed drugs.</p><p>Considering this, drug repurposing represents the promising strategy to fight tricky illness emerging in the future. Combined with polypharmacology, as a new therapeutic paradigm, the efforts of the scientific research towards the natural source compounds, though not new, could offer an opportunity to obtain the natural drugs scaffold useful against SARS-CoV-2 targets [<xref rid="B157-molecules-26-00632" ref-type="bibr">157</xref>]. Naturally occurring compounds recognizing SARS-CoV-2 druggable targets are reported in <xref rid="molecules-26-00632-t001" ref-type="table">Table 1</xref>.</p><p>Summarizing, numerous vitamin D clinical trials for COVID-19 could be useful to determine its effect on disease progression and post-exposure prophylaxis. One idea is that its supplementation can help patients to maintain sufficient serum levels of vitamin D as recommended by guidelines [<xref rid="B160-molecules-26-00632" ref-type="bibr">160</xref>]. The known potential of vitamin D modulating the innate immune response may be auspicious to prevent acute respiratory infection [<xref rid="B161-molecules-26-00632" ref-type="bibr">161</xref>]. Based on the knowledge that COVID-19 disproportionately affects race, ethnicity, minority groups, and the known vitamin D deficiency in the same groups, the use of natural derivatives may provide a chance for decreasing health disparities [<xref rid="B162-molecules-26-00632" ref-type="bibr">162</xref>].</p><p>LF is the naturally occurring compound mostly differing from the others. Clinical trials are designed to evaluate the local treatment of nasal mucosa with LF by using a spray formulation. The <italic>rationale</italic> of the implication of LF for COVID-19 prevention has the following fundaments: reverting the iron disorders due to the viral colonization, modulating the immune response or down-regulating the pro-inflammatory cytokines released by the viral inflammation [<xref rid="B67-molecules-26-00632" ref-type="bibr">67</xref>].</p><p>Among the flavonoid-based compounds, only quercetin is undergoing clinical trial due to its anti-inflammatory and scavenging activity. In detail, its dose scheduled is 500&#x02013;1000 mg for prophylaxis and treatment, respectively [<xref rid="B78-molecules-26-00632" ref-type="bibr">78</xref>].</p><p>Quercetin, in combination with zinc, bromelain and vitamin C, is recruited in clinical trials [<xref rid="B77-molecules-26-00632" ref-type="bibr">77</xref>]. Several clinical trials on resveratrol, artemisinin, glycyrrhizin, colchicine, berberine, and tetrandrine have been designed and are going on.</p><p>These compounds are characterized by well-known beneficial activities other than the antiviral implications against COVID-19 above-mentioned. Since these components are already taken differently in the daily diet, it could be challenging to attribute the antiviral properties to these natural compounds directly. Still, their assumption could be valuable for human health protection and to positively fill health equity.</p><p>Herein, terpenes, anthraquinones, flavonoids, stilbenes, steroid-based scaffold, quinone derivatives, and polyphenols have been summarized based on their current update in the recognition and validation of the SARS-CoV-2 druggable targets.</p><p>Although some of these have several drawbacks and lead to inconsistent results [<xref rid="B2-molecules-26-00632" ref-type="bibr">2</xref>,<xref rid="B163-molecules-26-00632" ref-type="bibr">163</xref>,<xref rid="B164-molecules-26-00632" ref-type="bibr">164</xref>,<xref rid="B165-molecules-26-00632" ref-type="bibr">165</xref>,<xref rid="B166-molecules-26-00632" ref-type="bibr">166</xref>,<xref rid="B167-molecules-26-00632" ref-type="bibr">167</xref>,<xref rid="B168-molecules-26-00632" ref-type="bibr">168</xref>,<xref rid="B169-molecules-26-00632" ref-type="bibr">169</xref>,<xref rid="B170-molecules-26-00632" ref-type="bibr">170</xref>]. In this regard, we would like to provide critical thought. Undoubtedly, the computational tools are valid instruments for the drug identification process, but the support of these preliminary investigations with experimental biological data are strictly required. Although these feelings can appear obvious, we believe this concept should be stressed to avoid the spread of disinformation or to prevent equivocal scientific conclusions. Most investigations were carried out on therapeutic benefits of phytochemicals, according to their known antiviral, anti-inflammatory and immunoregulatory properties. Several research teams conclude by asserting that the use of polyphenolic compounds, anthraquinones and flavonoids, and steroid-based molecules for COVID-19 treatment can appear speculative. In fact, no clear evidence from well-drawn clinical trials has been reported so far. On the other hand, dietary use of these phytochemical derivatives is known to provide several benefits to humans. The safety and efficacy of the reported natural compounds in preclinical and clinical trials must be still assessed to establish their use and application in COVID-19 infection. In this perspective, the dietary nature and pleiotropic effects make natural occurring compounds a fascinating candidate for further investigation.</p><p>Moreover, rational drug design highlights the possible binding mode of these compounds towards the key anti-SARS-CoV-2 targets. These data could be useful to suggest structural chemical modifications to improve the in-silico binding affinity. We expect scientists to perform relevant experimental studies to provide new derivatives within COVID-19 prevention and treatment, starting from the appropriate and most promising natural scaffolds.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors acknowledge the POR CALABRIA FESR-FSE 2014-2020 SISTABENE project.</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualisation, I.R., F.M., A.L., and S.A.; writing&#x02014;original draft preparation, I.R., F.M., and A.L.; writing&#x02014;review and editing, I.R., F.M., and A.L.; supervision, S.A. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-26-00632"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>P.</given-names></name><name><surname>Yang</surname><given-names>X.-L.</given-names></name><name><surname>Wang</surname><given-names>X.-G.</given-names></name><name><surname>Hu</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Si</surname><given-names>H.-R.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Huang</surname><given-names>C.-L.</given-names></name><etal/></person-group><article-title>A pneumonia outbreak associated with a new coronavirus of probable bat origin</article-title><source>Nature</source><year>2020</year><volume>579</volume><fpage>270</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2012-7</pub-id><?supplied-pmid 32015507?><pub-id pub-id-type="pmid">32015507</pub-id></element-citation></ref><ref id="B2-molecules-26-00632"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borba</surname><given-names>M.G.S.</given-names></name><name><surname>Val</surname><given-names>F.F.A.</given-names></name><name><surname>Hajjar</surname><given-names>L.A.</given-names></name><name><surname>Pinto</surname><given-names>R.C.</given-names></name><name><surname>Balieiro</surname><given-names>A.A.S.</given-names></name><name><surname>Pacheco</surname><given-names>A.G.F.</given-names></name><name><surname>Santos</surname><given-names>J.D.O.</given-names></name><name><surname>Naveca</surname><given-names>F.G.</given-names></name><name><surname>Xavier</surname><given-names>M.S.</given-names></name><name><surname>Siqueira</surname><given-names>A.M.</given-names></name><etal/></person-group><article-title>Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial</article-title><source>JAMA Netw. Open</source><year>2020</year><volume>3</volume><fpage>e208857</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.8857</pub-id><?supplied-pmid 32330277?><pub-id pub-id-type="pmid">32330277</pub-id></element-citation></ref><ref id="B3-molecules-26-00632"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J.T.</given-names></name><name><surname>Leung</surname><given-names>K.</given-names></name><name><surname>Leung</surname><given-names>G.M.</given-names></name></person-group><article-title>Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study</article-title><source>Lancet</source><year>2020</year><volume>395</volume><fpage>689</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30260-9</pub-id><pub-id pub-id-type="pmid">32014114</pub-id></element-citation></ref><ref id="B4-molecules-26-00632"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliver</surname><given-names>S.E.</given-names></name><name><surname>Gargano</surname><given-names>J.W.</given-names></name><name><surname>Marin</surname><given-names>M.</given-names></name><name><surname>Wallace</surname><given-names>M.</given-names></name><name><surname>Curran</surname><given-names>K.G.</given-names></name><name><surname>Chamberland</surname><given-names>M.</given-names></name><name><surname>McClung</surname><given-names>N.</given-names></name><name><surname>Campos-Outcalt</surname><given-names>D.</given-names></name><name><surname>Morgan</surname><given-names>R.L.</given-names></name><name><surname>Mbaeyi</surname><given-names>S.</given-names></name><etal/></person-group><article-title>The Advisory Committee on Immunization Practices&#x02019; Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine&#x02014;United States, December 2020</article-title><source>MMWR. Morb. Mortal. Wkly. Rep.</source><year>2020</year><volume>69</volume><fpage>1922</fpage><lpage>1924</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6950e2</pub-id><?supplied-pmid 33332292?><pub-id pub-id-type="pmid">33332292</pub-id></element-citation></ref><ref id="B5-molecules-26-00632"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasconcelos</surname><given-names>M.H.</given-names></name><name><surname>Alcaro</surname><given-names>S.</given-names></name><name><surname>Arechavala-Gomeza</surname><given-names>V.</given-names></name><name><surname>Baumbach</surname><given-names>J.</given-names></name><name><surname>Borges</surname><given-names>F.</given-names></name><name><surname>Brevini</surname><given-names>T.A.</given-names></name><name><surname>Rivas</surname><given-names>J.D.L.</given-names></name><name><surname>Devaux</surname><given-names>Y.</given-names></name><name><surname>Hozak</surname><given-names>P.</given-names></name><name><surname>Kein&#x000e4;nen-Toivola</surname><given-names>M.M.</given-names></name><etal/></person-group><article-title>Joining European Scientific Forces to Face Pandemics</article-title><source>Trends Microbiol.</source><year>2020</year><pub-id pub-id-type="doi">10.1016/j.tim.2020.10.008</pub-id></element-citation></ref><ref id="B6-molecules-26-00632"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salpini</surname><given-names>R.</given-names></name><name><surname>Alkhatib</surname><given-names>M.</given-names></name><name><surname>Costa</surname><given-names>G.</given-names></name><name><surname>Piermatteo</surname><given-names>L.</given-names></name><name><surname>Ambrosio</surname><given-names>F.A.</given-names></name><name><surname>Di Maio</surname><given-names>V.C.</given-names></name><name><surname>Scutari</surname><given-names>R.</given-names></name><name><surname>Duca</surname><given-names>L.</given-names></name><name><surname>Berno</surname><given-names>G.</given-names></name><name><surname>Fabeni</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control</article-title><source>J. Antimicrob. Chemother.</source><year>2020</year><pub-id pub-id-type="doi">10.1093/jac/dkaa444</pub-id></element-citation></ref><ref id="B7-molecules-26-00632"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortuso</surname><given-names>F.</given-names></name><name><surname>Mercatelli</surname><given-names>D.</given-names></name><name><surname>Guzzi</surname><given-names>P.H.</given-names></name><name><surname>Giorgi</surname><given-names>F.M.</given-names></name></person-group><article-title>Structural Genetics of circulating variants affecting the SARS CoV-2 Spike/human ACE2 complex</article-title><source>bioRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.09.09.289074</pub-id></element-citation></ref><ref id="B8-molecules-26-00632"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Z.</given-names></name><name><surname>Xiao</surname><given-names>Y.</given-names></name><name><surname>Kang</surname><given-names>L.</given-names></name><name><surname>Ma</surname><given-names>W.</given-names></name><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Zhong</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Genomic Diversity of Severe Acute Respiratory Syndrome&#x02013;Coronavirus 2 in Patients with Coronavirus Disease 2019</article-title><source>Clin. Infect. Dis.</source><year>2020</year><volume>71</volume><fpage>713</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1093/cid/ciaa203</pub-id><pub-id pub-id-type="pmid">32129843</pub-id></element-citation></ref><ref id="B9-molecules-26-00632"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plante</surname><given-names>J.A.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Xia</surname><given-names>H.</given-names></name><name><surname>Johnson</surname><given-names>B.A.</given-names></name><name><surname>Lokugamage</surname><given-names>K.G.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Muruato</surname><given-names>A.E.</given-names></name><name><surname>Zou</surname><given-names>J.</given-names></name><name><surname>Fontes-Garfias</surname><given-names>C.R.</given-names></name><etal/></person-group><article-title>Spike mutation D614G alters SARS-CoV-2 fitness</article-title><source>Nature</source><year>2020</year><pub-id pub-id-type="doi">10.1038/s41586-020-2895-3</pub-id></element-citation></ref><ref id="B10-molecules-26-00632"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagetta</surname><given-names>D.</given-names></name><name><surname>Maruca</surname><given-names>A.</given-names></name><name><surname>Lupia</surname><given-names>A.</given-names></name><name><surname>Mesiti</surname><given-names>F.</given-names></name><name><surname>Catalano</surname><given-names>R.</given-names></name><name><surname>Romeo</surname><given-names>I.</given-names></name><name><surname>Moraca</surname><given-names>F.</given-names></name><name><surname>Ambrosio</surname><given-names>F.A.</given-names></name><name><surname>Costa</surname><given-names>G.</given-names></name><name><surname>Artese</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome</article-title><source>Eur. J. Med. Chem.</source><year>2020</year><volume>186</volume><fpage>111903</fpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2019.111903</pub-id><pub-id pub-id-type="pmid">31787360</pub-id></element-citation></ref><ref id="B11-molecules-26-00632"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruca</surname><given-names>A.</given-names></name><name><surname>Catalano</surname><given-names>R.</given-names></name><name><surname>Bagetta</surname><given-names>D.</given-names></name><name><surname>Mesiti</surname><given-names>F.</given-names></name><name><surname>Ambrosio</surname><given-names>F.A.</given-names></name><name><surname>Romeo</surname><given-names>I.</given-names></name><name><surname>Moraca</surname><given-names>F.</given-names></name><name><surname>Rocca</surname><given-names>R.</given-names></name><name><surname>Ortuso</surname><given-names>F.</given-names></name><name><surname>Artese</surname><given-names>A.</given-names></name><etal/></person-group><article-title>The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile</article-title><source>Eur. J. Med. Chem.</source><year>2019</year><volume>181</volume><fpage>111579</fpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2019.111579</pub-id><?supplied-pmid 31398616?><pub-id pub-id-type="pmid">31398616</pub-id></element-citation></ref><ref id="B12-molecules-26-00632"><label>12.</label><element-citation publication-type="journal"><article-title>Medicinal plants and primary health care: Part 2</article-title><source>Essent. Drugs Monit.</source><year>1991</year><volume>11</volume><fpage>15</fpage><lpage>17</lpage></element-citation></ref><ref id="B13-molecules-26-00632"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narkhede</surname><given-names>R.R.</given-names></name><name><surname>Pise</surname><given-names>A.V.</given-names></name><name><surname>Cheke</surname><given-names>R.S.</given-names></name><name><surname>Shinde</surname><given-names>S.D.</given-names></name></person-group><article-title>Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences</article-title><source>Nat. Prod. Bioprospect.</source><year>2020</year><volume>10</volume><fpage>297</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1007/s13659-020-00253-1</pub-id><?supplied-pmid 32557405?><pub-id pub-id-type="pmid">32557405</pub-id></element-citation></ref><ref id="B14-molecules-26-00632"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>B.</given-names></name><name><surname>Wolfender</surname><given-names>J.-L.</given-names></name><name><surname>Dias</surname><given-names>D.A.</given-names></name></person-group><article-title>The pharmaceutical industry and natural products: Historical status and new trends</article-title><source>Phytochem. Rev.</source><year>2015</year><volume>14</volume><fpage>299</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1007/s11101-014-9367-z</pub-id></element-citation></ref><ref id="B15-molecules-26-00632"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Firn</surname><given-names>R.D.</given-names></name><name><surname>Jones</surname><given-names>C.G.</given-names></name></person-group><article-title>Natural Products&#x02014;A Simple Model to Explain Chemical Diversity</article-title><source>Nat. Prod. Rep.</source><year>2003</year><volume>20</volume><fpage>382</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1039/b208815k</pub-id><pub-id pub-id-type="pmid">12964834</pub-id></element-citation></ref><ref id="B16-molecules-26-00632"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>D.A.</given-names></name><name><surname>Urban</surname><given-names>S.</given-names></name><name><surname>Roessner</surname><given-names>U.</given-names></name></person-group><article-title>A Historical Overview of Natural Products in Drug Discovery</article-title><source>Metabolites</source><year>2012</year><volume>2</volume><fpage>303</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.3390/metabo2020303</pub-id><pub-id pub-id-type="pmid">24957513</pub-id></element-citation></ref><ref id="B17-molecules-26-00632"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catalogna</surname><given-names>G.</given-names></name><name><surname>Moraca</surname><given-names>F.</given-names></name><name><surname>D&#x02019;Antona</surname><given-names>L.</given-names></name><name><surname>Dattilo</surname><given-names>V.</given-names></name><name><surname>Perrotti</surname><given-names>G.</given-names></name><name><surname>Lupia</surname><given-names>A.</given-names></name><name><surname>Costa</surname><given-names>G.</given-names></name><name><surname>Ortuso</surname><given-names>F.</given-names></name><name><surname>Iuliano</surname><given-names>R.</given-names></name><name><surname>Trapasso</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Review about the multi-target profile of resveratrol and its implication in the SGK1 inhibition</article-title><source>Eur. J. Med. Chem.</source><year>2019</year><volume>183</volume><fpage>111675</fpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2019.111675</pub-id><pub-id pub-id-type="pmid">31539779</pub-id></element-citation></ref><ref id="B18-molecules-26-00632"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deorukhkar</surname><given-names>A.</given-names></name><name><surname>Krishnan</surname><given-names>S.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Back to basics: How natural products can provide the basis for new therapeutics</article-title><source>Expert Opin. Investig. Drugs</source><year>2007</year><volume>16</volume><fpage>1753</fpage><lpage>1773</lpage><pub-id pub-id-type="doi">10.1517/13543784.16.11.1753</pub-id><?supplied-pmid 17970636?><pub-id pub-id-type="pmid">17970636</pub-id></element-citation></ref><ref id="B19-molecules-26-00632"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lani</surname><given-names>R.</given-names></name><name><surname>Hassandarvish</surname><given-names>P.</given-names></name><name><surname>Shu</surname><given-names>M.-H.</given-names></name><name><surname>Phoon</surname><given-names>W.H.</given-names></name><name><surname>Chu</surname><given-names>J.J.H.</given-names></name><name><surname>Higgs</surname><given-names>S.</given-names></name><name><surname>VanLandingham</surname><given-names>D.</given-names></name><name><surname>Abu Bakar</surname><given-names>S.</given-names></name><name><surname>Zandi</surname><given-names>K.</given-names></name></person-group><article-title>Antiviral activity of selected flavonoids against Chikungunya virus</article-title><source>Antivir. Res.</source><year>2016</year><volume>133</volume><fpage>50</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2016.07.009</pub-id><?supplied-pmid 27460167?><pub-id pub-id-type="pmid">27460167</pub-id></element-citation></ref><ref id="B20-molecules-26-00632"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zakaryan</surname><given-names>H.</given-names></name><name><surname>Arabyan</surname><given-names>E.</given-names></name><name><surname>Oo</surname><given-names>A.</given-names></name><name><surname>Zandi</surname><given-names>K.</given-names></name></person-group><article-title>Flavonoids: Promising natural compounds against viral infections</article-title><source>Arch. Virol.</source><year>2017</year><volume>162</volume><fpage>2539</fpage><lpage>2551</lpage><pub-id pub-id-type="doi">10.1007/s00705-017-3417-y</pub-id><?supplied-pmid 28547385?><pub-id pub-id-type="pmid">28547385</pub-id></element-citation></ref><ref id="B21-molecules-26-00632"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Artese</surname><given-names>A.</given-names></name><name><surname>Svicher</surname><given-names>V.</given-names></name><name><surname>Costa</surname><given-names>G.</given-names></name><name><surname>Salpini</surname><given-names>R.</given-names></name><name><surname>Di Maio</surname><given-names>V.C.</given-names></name><name><surname>Alkhatib</surname><given-names>M.</given-names></name><name><surname>Ambrosio</surname><given-names>F.A.</given-names></name><name><surname>Santoro</surname><given-names>M.M.</given-names></name><name><surname>Assaraf</surname><given-names>Y.G.</given-names></name><name><surname>Alcaro</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses</article-title><source>Drug Resist. Updat.</source><year>2020</year><volume>53</volume><fpage>100721</fpage><pub-id pub-id-type="doi">10.1016/j.drup.2020.100721</pub-id><?supplied-pmid 33132205?><pub-id pub-id-type="pmid">33132205</pub-id></element-citation></ref><ref id="B22-molecules-26-00632"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berretta</surname><given-names>A.A.</given-names></name><name><surname>Silveira</surname><given-names>M.A.D.</given-names></name><name><surname>Capcha</surname><given-names>J.M.C.</given-names></name><name><surname>De Jong</surname><given-names>D.</given-names></name></person-group><article-title>Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19</article-title><source>Biomed. Pharmacother.</source><year>2020</year><volume>131</volume><fpage>110622</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2020.110622</pub-id><?supplied-pmid 32890967?><pub-id pub-id-type="pmid">32890967</pub-id></element-citation></ref><ref id="B23-molecules-26-00632"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benskin</surname><given-names>L.L.</given-names></name></person-group><article-title>A basic review of the preliminary evidence that COVID-19 risk and severity is increased in vitamin D deficiency</article-title><source>Front. Public Health</source><year>2020</year><volume>8</volume><fpage>513</fpage><pub-id pub-id-type="doi">10.3389/fpubh.2020.00513</pub-id><?supplied-pmid 33014983?><pub-id pub-id-type="pmid">33014983</pub-id></element-citation></ref><ref id="B24-molecules-26-00632"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cannell</surname><given-names>J.J.</given-names></name><name><surname>Vieth</surname><given-names>R.</given-names></name><name><surname>Umhau</surname><given-names>J.C.</given-names></name><name><surname>Holick</surname><given-names>M.F.</given-names></name><name><surname>Grant</surname><given-names>W.B.</given-names></name><name><surname>Madronich</surname><given-names>S.</given-names></name><name><surname>Garland</surname><given-names>C.F.</given-names></name><name><surname>Giovannucci</surname><given-names>E.</given-names></name></person-group><article-title>Epidemic influenza and vitamin D</article-title><source>Epidemiol. Infect.</source><year>2006</year><volume>134</volume><fpage>1129</fpage><lpage>1140</lpage><pub-id pub-id-type="doi">10.1017/S0950268806007175</pub-id><?supplied-pmid 16959053?><pub-id pub-id-type="pmid">16959053</pub-id></element-citation></ref><ref id="B25-molecules-26-00632"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bracale</surname><given-names>R.</given-names></name><name><surname>Vaccaro</surname><given-names>C.M.</given-names></name><name><surname>Coletta</surname><given-names>V.</given-names></name><name><surname>Cricelli</surname><given-names>C.</given-names></name><name><surname>Gamaleri</surname><given-names>F.C.</given-names></name><name><surname>Parazzini</surname><given-names>F.</given-names></name><name><surname>Carruba</surname><given-names>M.</given-names></name></person-group><article-title>Nutrition behaviour and compliance with the Mediterranean diet pyramid recommendations: An Italian survey-based study</article-title><source>Eat. Weight Disord. Stud. Anorex. Bulim. Obesity</source><year>2020</year><volume>25</volume><fpage>1789</fpage><lpage>1798</lpage><pub-id pub-id-type="doi">10.1007/s40519-019-00807-4</pub-id></element-citation></ref><ref id="B26-molecules-26-00632"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azrielant</surname><given-names>S.</given-names></name><name><surname>Shoenfeld</surname><given-names>Y.</given-names></name></person-group><article-title>Vitamin D and the immune system</article-title><source>Isr. Med. Assoc. J.</source><year>2017</year><volume>19</volume><fpage>510</fpage><lpage>511</lpage><pub-id pub-id-type="pmid">28825771</pub-id></element-citation></ref><ref id="B27-molecules-26-00632"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>D.A.</given-names></name><name><surname>Norton</surname><given-names>R.</given-names></name></person-group><article-title>Vitamin D and respiratory health</article-title><source>Clin. Exp. Immunol.</source><year>2009</year><volume>158</volume><fpage>20</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2249.2009.04001.x</pub-id><pub-id pub-id-type="pmid">19737226</pub-id></element-citation></ref><ref id="B28-molecules-26-00632"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martineau</surname><given-names>A.R.</given-names></name><name><surname>Forouhi</surname><given-names>N.G.</given-names></name></person-group><article-title>Vitamin D for COVID-19: A case to answer?</article-title><source>Lancet Diabetes Endocrinol.</source><year>2020</year><volume>8</volume><fpage>735</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1016/S2213-8587(20)30268-0</pub-id><pub-id pub-id-type="pmid">32758429</pub-id></element-citation></ref><ref id="B29-molecules-26-00632"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charoute</surname><given-names>H.</given-names></name><name><surname>Saile</surname><given-names>R.</given-names></name><name><surname>Barakat</surname><given-names>A.</given-names></name></person-group><article-title>Computational Approach Revealed Potential Affinity of Antiasthmatics against Receptor Binding Domain of 2019n-Cov Spike Glycoprotein</article-title><source>ChemRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.26434/chemrxiv.12115638.v1</pub-id></element-citation></ref><ref id="B30-molecules-26-00632"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weir</surname><given-names>E.K.</given-names></name><name><surname>Thenappan</surname><given-names>T.</given-names></name><name><surname>Bhargava</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name></person-group><article-title>Does vitamin D deficiency increase the severity of COVID-19?</article-title><source>Clin. Med.</source><year>2020</year><volume>20</volume><fpage>e107</fpage><lpage>e108</lpage><pub-id pub-id-type="doi">10.7861/clinmed.2020-0301</pub-id></element-citation></ref><ref id="B31-molecules-26-00632"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>A.</given-names></name><name><surname>Chaurasia</surname><given-names>R.</given-names></name><name><surname>Sengar</surname><given-names>N.S.</given-names></name><name><surname>Singh</surname><given-names>M.</given-names></name><name><surname>Mahor</surname><given-names>S.</given-names></name><name><surname>Narain</surname><given-names>S.</given-names></name></person-group><article-title>Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><fpage>20191</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-77093-z</pub-id><?supplied-pmid 33214648?><pub-id pub-id-type="pmid">33214648</pub-id></element-citation></ref><ref id="B32-molecules-26-00632"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torjesen</surname><given-names>I.</given-names></name></person-group><article-title>Evidence does not support vitamin D for reducing respiratory infections, reviews conclude</article-title><source>BMJ</source><year>2020</year><volume>369</volume><fpage>m2629</fpage><pub-id pub-id-type="doi">10.1136/bmj.m2629</pub-id><?supplied-pmid 32606036?><pub-id pub-id-type="pmid">32606036</pub-id></element-citation></ref><ref id="B33-molecules-26-00632"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kow</surname><given-names>C.S.</given-names></name><name><surname>Hadi</surname><given-names>M.A.</given-names></name><name><surname>Hasan</surname><given-names>S.S.</given-names></name></person-group><article-title>Vitamin D Supplementation in Influenza and COVID-19 Infections Comment on: &#x0201c;Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths&#x0201d; <italic>Nutrients</italic></article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>1626</elocation-id><pub-id pub-id-type="doi">10.3390/nu12061626</pub-id><?supplied-pmid 32492809?><pub-id pub-id-type="pmid">32492809</pub-id></element-citation></ref><ref id="B34-molecules-26-00632"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>N.</given-names></name></person-group><article-title>Role of vitamin D in preventing of COVID-19 infection, progression and severity</article-title><source>J. Infect. Public Health</source><year>2020</year><volume>13</volume><fpage>1373</fpage><lpage>1380</lpage><pub-id pub-id-type="doi">10.1016/j.jiph.2020.06.021</pub-id><pub-id pub-id-type="pmid">32605780</pub-id></element-citation></ref><ref id="B35-molecules-26-00632"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lykkesfeldt</surname><given-names>J.</given-names></name><name><surname>Michels</surname><given-names>A.J.</given-names></name><name><surname>Frei</surname><given-names>B.</given-names></name></person-group><article-title>Vitamin C</article-title><source>Adv. Nutr.</source><year>2014</year><volume>5</volume><fpage>16</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.3945/an.113.005157</pub-id><pub-id pub-id-type="pmid">24425716</pub-id></element-citation></ref><ref id="B36-molecules-26-00632"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>R.Z.</given-names></name></person-group><article-title>Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?</article-title><source>Med. Drug Discov.</source><year>2020</year><volume>5</volume><fpage>100028</fpage><pub-id pub-id-type="doi">10.1016/j.medidd.2020.100028</pub-id><?supplied-pmid 32328576?><pub-id pub-id-type="pmid">32328576</pub-id></element-citation></ref><ref id="B37-molecules-26-00632"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerullo</surname><given-names>G.</given-names></name><name><surname>Negro</surname><given-names>M.</given-names></name><name><surname>Parimbelli</surname><given-names>M.</given-names></name><name><surname>Pecoraro</surname><given-names>M.</given-names></name><name><surname>Perna</surname><given-names>S.</given-names></name><name><surname>Liguori</surname><given-names>G.</given-names></name><name><surname>Rondanelli</surname><given-names>M.</given-names></name><name><surname>Cena</surname><given-names>H.</given-names></name><name><surname>D&#x02019;Antona</surname><given-names>G.</given-names></name></person-group><article-title>The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><fpage>574029</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2020.574029</pub-id><?supplied-pmid 33193359?><pub-id pub-id-type="pmid">33193359</pub-id></element-citation></ref><ref id="B38-molecules-26-00632"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padayatty</surname><given-names>S.J.</given-names></name><name><surname>Katz</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Eck</surname><given-names>P.</given-names></name><name><surname>Kwon</surname><given-names>O.</given-names></name><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Corpe</surname><given-names>C.</given-names></name><name><surname>Dutta</surname><given-names>A.</given-names></name><name><surname>Dutta</surname><given-names>S.K.</given-names></name><etal/></person-group><article-title>Vitamin C as an Antioxidant: Evaluation of Its Role in Disease Prevention</article-title><source>J. Am. Coll. Nutr.</source><year>2003</year><volume>22</volume><fpage>18</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1080/07315724.2003.10719272</pub-id><pub-id pub-id-type="pmid">12569111</pub-id></element-citation></ref><ref id="B39-molecules-26-00632"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Peng</surname><given-names>Z.</given-names></name></person-group><article-title>Intravenous high-dose vitamin C for the treatment of severe COVID-19: Study protocol for a multicentre randomised controlled trial</article-title><source>BMJ Open</source><year>2020</year><volume>10</volume><fpage>e039519</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2020-039519</pub-id></element-citation></ref><ref id="B40-molecules-26-00632"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemil&#x000e4;</surname><given-names>H.</given-names></name><name><surname>Chalker</surname><given-names>E.</given-names></name></person-group><article-title>Vitamin C for preventing and treating the common cold</article-title><source>Cochrane Database Syst. Rev.</source><year>2013</year><pub-id pub-id-type="doi">10.1002/14651858.CD000980.pub4</pub-id></element-citation></ref><ref id="B41-molecules-26-00632"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemil&#x000e4;</surname><given-names>H.</given-names></name><name><surname>Chalker</surname><given-names>E.</given-names></name></person-group><article-title>Vitamin C as a Possible Therapy for COVID-19</article-title><source>Infect. Chemother.</source><year>2020</year><volume>52</volume><fpage>222</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.3947/ic.2020.52.2.222</pub-id><?supplied-pmid 32410417?><pub-id pub-id-type="pmid">32410417</pub-id></element-citation></ref><ref id="B42-molecules-26-00632"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemil&#x000e4;</surname><given-names>H.</given-names></name><name><surname>Chalker</surname><given-names>E.</given-names></name></person-group><article-title>Vitamin C Can Shorten the Length of Stay in the ICU: A Meta-Analysis</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><elocation-id>708</elocation-id><pub-id pub-id-type="doi">10.3390/nu11040708</pub-id><?supplied-pmid 30934660?><pub-id pub-id-type="pmid">30934660</pub-id></element-citation></ref><ref id="B43-molecules-26-00632"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemil&#x000e4;</surname><given-names>H.</given-names></name><name><surname>Chalker</surname><given-names>E.</given-names></name></person-group><article-title>Vitamin C may reduce the duration of mechanical ventilation in critically ill patients: A meta-regression analysis</article-title><source>J. Intensive Care</source><year>2020</year><volume>8</volume><fpage>15</fpage><pub-id pub-id-type="doi">10.1186/s40560-020-0432-y</pub-id><?supplied-pmid 32047636?><pub-id pub-id-type="pmid">32047636</pub-id></element-citation></ref><ref id="B44-molecules-26-00632"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Rao</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Guo</surname><given-names>G.</given-names></name><name><surname>Luo</surname><given-names>G.</given-names></name><name><surname>Meng</surname><given-names>Z.</given-names></name><name><surname>De Backer</surname><given-names>D.</given-names></name><name><surname>Xiang</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Pilot trial of high-dose vitamin C in critically ill COVID-19 patients</article-title><source>Ann. Intensiv. Care</source><year>2021</year><volume>11</volume><fpage>5</fpage><pub-id pub-id-type="doi">10.1186/s13613-020-00792-3</pub-id><?supplied-pmid 33420963?><pub-id pub-id-type="pmid">33420963</pub-id></element-citation></ref><ref id="B45-molecules-26-00632"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carr</surname><given-names>A.C.</given-names></name><name><surname>Rowe</surname><given-names>S.</given-names></name></person-group><article-title>The Emerging Role of Vitamin C in the Prevention and Treatment of COVID-19</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><elocation-id>3286</elocation-id><pub-id pub-id-type="doi">10.3390/nu12113286</pub-id></element-citation></ref><ref id="B46-molecules-26-00632"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name></person-group><article-title>Mini-Review on the Roles of Vitamin C, Vitamin D, and Selenium in the Immune System against COVID-19</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>5346</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25225346</pub-id></element-citation></ref><ref id="B47-molecules-26-00632"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>B.F.</given-names></name><name><surname>Baker</surname><given-names>H.M.</given-names></name><name><surname>Morris</surname><given-names>G.E.</given-names></name><name><surname>Rumball</surname><given-names>S.V.</given-names></name><name><surname>Baker</surname><given-names>E.N.</given-names></name></person-group><article-title>Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins</article-title><source>Nature</source><year>1990</year><volume>344</volume><fpage>784</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1038/344784a0</pub-id><pub-id pub-id-type="pmid">2330032</pub-id></element-citation></ref><ref id="B48-molecules-26-00632"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogel</surname><given-names>H.J.</given-names></name></person-group><article-title>Lactoferrin, a bird&#x02019;s eye view</article-title><source>Biochem. Cell Biol.</source><year>2012</year><volume>90</volume><fpage>233</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1139/o2012-016</pub-id><pub-id pub-id-type="pmid">22540735</pub-id></element-citation></ref><ref id="B49-molecules-26-00632"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karav</surname><given-names>S.</given-names></name><name><surname>German</surname><given-names>J.B.</given-names></name><name><surname>Rouqui&#x000e9;</surname><given-names>C.</given-names></name><name><surname>Le Parc</surname><given-names>A.</given-names></name><name><surname>Barile</surname><given-names>D.</given-names></name></person-group><article-title>Studying Lactoferrin N-Glycosylation</article-title><source>Int. J. Mol. Sci.</source><year>2017</year><volume>18</volume><elocation-id>870</elocation-id><pub-id pub-id-type="doi">10.3390/ijms18040870</pub-id></element-citation></ref><ref id="B50-molecules-26-00632"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X.-L.</given-names></name><name><surname>Baker</surname><given-names>H.M.</given-names></name><name><surname>Shewry</surname><given-names>S.C.</given-names></name><name><surname>Jameson</surname><given-names>G.B.</given-names></name><name><surname>Baker</surname><given-names>E.N.</given-names></name></person-group><article-title>Structure of recombinant human lactoferrin expressed in Aspergillus awamori</article-title><source>Acta Crystallogr. Sect. D Biol. Crystallogr.</source><year>1999</year><volume>55</volume><fpage>403</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1107/S0907444998011226</pub-id><pub-id pub-id-type="pmid">10089347</pub-id></element-citation></ref><ref id="B51-molecules-26-00632"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Timilsena</surname><given-names>Y.P.</given-names></name><name><surname>Blanch</surname><given-names>E.</given-names></name><name><surname>Adhikari</surname><given-names>B.</given-names></name></person-group><article-title>Lactoferrin: Structure, function, denaturation and digestion</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>2019</year><volume>59</volume><fpage>580</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1080/10408398.2017.1381583</pub-id><?supplied-pmid 28933602?><pub-id pub-id-type="pmid">28933602</pub-id></element-citation></ref><ref id="B52-molecules-26-00632"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kell</surname><given-names>D.B.</given-names></name><name><surname>Heyden</surname><given-names>E.L.</given-names></name><name><surname>Pretorius</surname><given-names>E.</given-names></name></person-group><article-title>The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria</article-title><source>Front. Immunol.</source><year>2020</year><volume>11</volume><fpage>1221</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2020.01221</pub-id><?supplied-pmid 32574271?><pub-id pub-id-type="pmid">32574271</pub-id></element-citation></ref><ref id="B53-molecules-26-00632"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganz</surname><given-names>T.</given-names></name></person-group><article-title>Iron and infection</article-title><source>Int. J. Hematol.</source><year>2018</year><volume>107</volume><fpage>7</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1007/s12185-017-2366-2</pub-id><?supplied-pmid 29147843?><pub-id pub-id-type="pmid">29147843</pub-id></element-citation></ref><ref id="B54-molecules-26-00632"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siqueiros-Cend&#x000f3;n</surname><given-names>T.</given-names></name><name><surname>Ar&#x000e9;valo-Gallegos</surname><given-names>S.</given-names></name><name><surname>Iglesias-Figueroa</surname><given-names>B.F.</given-names></name><name><surname>Garc&#x000ed;a-Montoya</surname><given-names>I.A.</given-names></name><name><surname>Salazar-Mart&#x000ed;nez</surname><given-names>J.</given-names></name><name><surname>Rasc&#x000f3;n-Cruz</surname><given-names>Q.</given-names></name></person-group><article-title>Immunomodulatory effects of lactoferrin</article-title><source>Acta Pharmacol. Sin.</source><year>2014</year><volume>35</volume><fpage>557</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1038/aps.2013.200</pub-id><?supplied-pmid 24786230?><pub-id pub-id-type="pmid">24786230</pub-id></element-citation></ref><ref id="B55-molecules-26-00632"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>Y.A.</given-names></name><name><surname>Wong</surname><given-names>H.</given-names></name><name><surname>Ashida</surname><given-names>K.-Y.</given-names></name><name><surname>Schryvers</surname><given-names>A.B.</given-names></name><name><surname>L&#x000f6;nnerdal</surname><given-names>B.</given-names></name></person-group><article-title>The N1 Domain of Human Lactoferrin Is Required for Internalization by Caco-2 Cells and Targeting to the Nucleus</article-title><source>Biochemistry</source><year>2008</year><volume>47</volume><fpage>10915</fpage><lpage>10920</lpage><pub-id pub-id-type="doi">10.1021/bi8012164</pub-id><?supplied-pmid 18785755?><pub-id pub-id-type="pmid">18785755</pub-id></element-citation></ref><ref id="B56-molecules-26-00632"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutone</surname><given-names>A.</given-names></name><name><surname>Rosa</surname><given-names>L.</given-names></name><name><surname>Lepanto</surname><given-names>M.S.</given-names></name><name><surname>Scotti</surname><given-names>M.J.</given-names></name><name><surname>Berlutti</surname><given-names>F.</given-names></name><name><surname>Di Patti</surname><given-names>M.C.B.</given-names></name><name><surname>Musci</surname><given-names>G.</given-names></name><name><surname>Valenti</surname><given-names>P.</given-names></name></person-group><article-title>Lactoferrin Efficiently Counteracts the Inflammation-Induced Changes of the Iron Homeostasis System in Macrophages</article-title><source>Front. Immunol.</source><year>2017</year><volume>8</volume><fpage>705</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2017.00705</pub-id><?supplied-pmid 28663751?><pub-id pub-id-type="pmid">28663751</pub-id></element-citation></ref><ref id="B57-molecules-26-00632"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valenti</surname><given-names>P.</given-names></name><name><surname>Frioni</surname><given-names>A.</given-names></name><name><surname>Rossi</surname><given-names>A.</given-names></name><name><surname>Ranucci</surname><given-names>S.</given-names></name><name><surname>De Fino</surname><given-names>I.</given-names></name><name><surname>Cutone</surname><given-names>A.</given-names></name><name><surname>Rosa</surname><given-names>L.</given-names></name><name><surname>Bragonzi</surname><given-names>A.</given-names></name><name><surname>Berlutti</surname><given-names>F.</given-names></name></person-group><article-title>Aerosolized bovine lactoferrin reduces neutrophils and pro-inflammatory cytokines in mouse models of Pseudomonas aeruginosa lung infections</article-title><source>Biochem. Cell Biol.</source><year>2017</year><volume>95</volume><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1139/bcb-2016-0050</pub-id><?supplied-pmid 28129511?><pub-id pub-id-type="pmid">28129511</pub-id></element-citation></ref><ref id="B58-molecules-26-00632"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>N.</given-names></name><name><surname>Deng</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>K.</given-names></name><name><surname>Yang</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Jiang</surname><given-names>C.</given-names></name></person-group><article-title>Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><elocation-id>e23710</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0023710</pub-id><pub-id pub-id-type="pmid">21887302</pub-id></element-citation></ref><ref id="B59-molecules-26-00632"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berlutti</surname><given-names>F.</given-names></name><name><surname>Pantanella</surname><given-names>F.</given-names></name><name><surname>Natalizi</surname><given-names>T.</given-names></name><name><surname>Frioni</surname><given-names>A.</given-names></name><name><surname>Paesano</surname><given-names>R.</given-names></name><name><surname>Polimeni</surname><given-names>A.</given-names></name><name><surname>Valenti</surname><given-names>P.</given-names></name></person-group><article-title>Antiviral Properties of Lactoferrin&#x02014;A Natural Immunity Molecule</article-title><source>Molecules</source><year>2011</year><volume>16</volume><fpage>6992</fpage><lpage>7018</lpage><pub-id pub-id-type="doi">10.3390/molecules16086992</pub-id><pub-id pub-id-type="pmid">21847071</pub-id></element-citation></ref><ref id="B60-molecules-26-00632"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redwan</surname><given-names>E.M.</given-names></name><name><surname>Uversky</surname><given-names>V.N.</given-names></name><name><surname>El-Fakharany</surname><given-names>E.M.</given-names></name><name><surname>Al-Mehdar</surname><given-names>H.</given-names></name></person-group><article-title>Potential lactoferrin activity against pathogenic viruses</article-title><source>C. R. Biol.</source><year>2014</year><volume>337</volume><fpage>581</fpage><lpage>595</lpage><pub-id pub-id-type="doi">10.1016/j.crvi.2014.08.003</pub-id><pub-id pub-id-type="pmid">25282173</pub-id></element-citation></ref><ref id="B61-molecules-26-00632"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milanetti</surname><given-names>E.</given-names></name><name><surname>Miotto</surname><given-names>M.</given-names></name><name><surname>Di Rienzo</surname><given-names>L.</given-names></name><name><surname>Monti</surname><given-names>M.</given-names></name><name><surname>Gosti</surname><given-names>G.</given-names></name><name><surname>Ruocco</surname><given-names>G.</given-names></name></person-group><article-title>In-Silico evidence for two receptors based strategy of SARS-CoV-2</article-title><source>arXiv</source><year>2020</year><pub-id pub-id-type="arxiv">2003.11107</pub-id></element-citation></ref><ref id="B62-molecules-26-00632"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandelli</surname><given-names>A.</given-names></name><name><surname>Monti</surname><given-names>M.</given-names></name><name><surname>Milanetti</surname><given-names>E.</given-names></name><name><surname>Ponti</surname><given-names>R.D.</given-names></name><name><surname>Tartaglia</surname><given-names>G.G.</given-names></name></person-group><article-title>Structural analysis of SARS-CoV-2 and prediction of the human interactome</article-title><source>arXiv</source><year>2020</year><pub-id pub-id-type="arxiv">2003.13655</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkaa864</pub-id></element-citation></ref><ref id="B63-molecules-26-00632"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Chopra</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Wolfert</surname><given-names>M.A.</given-names></name><name><surname>Tompkins</surname><given-names>S.M.</given-names></name><name><surname>Boons</surname><given-names>G.J.</given-names></name></person-group><article-title>SARS-CoV-2 spike protein binds heparan sulfate in a length- and sequence-dependent manner</article-title><source>bioRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.05.10.087288</pub-id></element-citation></ref><ref id="B64-molecules-26-00632"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robson</surname><given-names>B.</given-names></name></person-group><article-title>The use of knowledge management tools in viroinformatics. Example study of a highly conserved sequence motif in Nsp3 of SARS-CoV-2 as a therapeutic target</article-title><source>Comput. Biol. Med.</source><year>2020</year><volume>125</volume><fpage>103963</fpage><pub-id pub-id-type="doi">10.1016/j.compbiomed.2020.103963</pub-id><pub-id pub-id-type="pmid">32828990</pub-id></element-citation></ref><ref id="B65-molecules-26-00632"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miotto</surname><given-names>M.</given-names></name><name><surname>Di Rienzo</surname><given-names>L.</given-names></name><name><surname>B&#x000f2;</surname><given-names>L.</given-names></name><name><surname>Boffi</surname><given-names>A.</given-names></name><name><surname>Ruocco</surname><given-names>G.</given-names></name><name><surname>Milanetti</surname><given-names>E.</given-names></name></person-group><article-title>Molecular mechanisms behind anti SARS-CoV-2 action of lactoferrin</article-title><source>arXiv</source><year>2020</year><pub-id pub-id-type="arxiv">2007.07341</pub-id></element-citation></ref><ref id="B66-molecules-26-00632"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campione</surname><given-names>E.</given-names></name><name><surname>Lanna</surname><given-names>C.</given-names></name><name><surname>Cosio</surname><given-names>T.</given-names></name><name><surname>Rosa</surname><given-names>L.</given-names></name><name><surname>Conte</surname><given-names>M.P.</given-names></name><name><surname>Iacovelli</surname><given-names>F.</given-names></name><name><surname>Romeo</surname><given-names>A.</given-names></name><name><surname>Falconi</surname><given-names>M.</given-names></name><name><surname>Del Vecchio</surname><given-names>C.</given-names></name><name><surname>Franchin</surname><given-names>E.</given-names></name></person-group><article-title>Pleiotropic effect of Lactoferrin in the prevention and treatment of COVID-19 infection: In vivo, in silico and in vitro preliminary evidences</article-title><source>bioRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.08.11.244996</pub-id></element-citation></ref><ref id="B67-molecules-26-00632"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campione</surname><given-names>E.</given-names></name><name><surname>Cosio</surname><given-names>T.</given-names></name><name><surname>Rosa</surname><given-names>L.</given-names></name><name><surname>Lanna</surname><given-names>C.</given-names></name><name><surname>Di Girolamo</surname><given-names>S.</given-names></name><name><surname>Gaziano</surname><given-names>R.</given-names></name><name><surname>Valenti</surname><given-names>P.</given-names></name><name><surname>Bianchi</surname><given-names>L.</given-names></name></person-group><article-title>Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>4903</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21144903</pub-id></element-citation></ref><ref id="B68-molecules-26-00632"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Wan</surname><given-names>L.</given-names></name><name><surname>Jiang</surname><given-names>M.</given-names></name><name><surname>Chu</surname><given-names>Y.</given-names></name></person-group><article-title>Lactoferrin for the treatment of COVID-19 (Review)</article-title><source>Exp. Ther. Med.</source><year>2020</year><volume>20</volume><fpage>272</fpage><pub-id pub-id-type="doi">10.3892/etm.2020.9402</pub-id><pub-id pub-id-type="pmid">33199997</pub-id></element-citation></ref><ref id="B69-molecules-26-00632"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chimenti</surname><given-names>F.</given-names></name><name><surname>Cottiglia</surname><given-names>F.</given-names></name><name><surname>Bonsignore</surname><given-names>L.</given-names></name><name><surname>Casu</surname><given-names>L.</given-names></name><name><surname>Casu</surname><given-names>M.</given-names></name><name><surname>Floris</surname><given-names>C.</given-names></name><name><surname>Secci</surname><given-names>D.</given-names></name><name><surname>Bolasco</surname><given-names>A.</given-names></name><name><surname>Chimenti</surname><given-names>P.</given-names></name><name><surname>Granese</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Quercetin as the active principle of <italic>Hypericum hircinum</italic> exerts a selective inhibitory activity against MAO-A: Extraction, Biological analysis, and computational study</article-title><source>J. Nat. Prod.</source><year>2006</year><volume>69</volume><fpage>945</fpage><lpage>949</lpage><pub-id pub-id-type="doi">10.1021/np060015w</pub-id><pub-id pub-id-type="pmid">16792415</pub-id></element-citation></ref><ref id="B70-molecules-26-00632"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Jiang</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name></person-group><article-title>Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry</article-title><source>Viruses</source><year>2016</year><volume>8</volume><elocation-id>6</elocation-id><pub-id pub-id-type="doi">10.3390/v8010006</pub-id></element-citation></ref><ref id="B71-molecules-26-00632"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abian</surname><given-names>O.</given-names></name><name><surname>Ortega-Alarcon</surname><given-names>D.</given-names></name><name><surname>Jimenez-Alesanco</surname><given-names>A.</given-names></name><name><surname>Ceballos-Laita</surname><given-names>L.</given-names></name><name><surname>Vega</surname><given-names>S.</given-names></name><name><surname>Reyburn</surname><given-names>H.T.</given-names></name><name><surname>Rizzuti</surname><given-names>B.</given-names></name><name><surname>Vel&#x000e1;zquez-Campoy</surname><given-names>A.</given-names></name></person-group><article-title>Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening</article-title><source>Int. J. Biol. Macromol.</source><year>2020</year><volume>164</volume><fpage>1693</fpage><lpage>1703</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.07.235</pub-id><?supplied-pmid 32745548?><pub-id pub-id-type="pmid">32745548</pub-id></element-citation></ref><ref id="B72-molecules-26-00632"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeRosa</surname><given-names>G.</given-names></name><name><surname>Maffioli</surname><given-names>P.</given-names></name><name><surname>D&#x02019;Angelo</surname><given-names>A.</given-names></name><name><surname>Di Pierro</surname><given-names>F.</given-names></name></person-group><article-title>A role for quercetin in coronavirus disease 2019 (COVID-19)</article-title><source>Phytother. Res.</source><year>2020</year><pub-id pub-id-type="doi">10.1002/ptr.6887</pub-id><?supplied-pmid 33034398?><pub-id pub-id-type="pmid">33034398</pub-id></element-citation></ref><ref id="B73-molecules-26-00632"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>J.C.</given-names></name></person-group><article-title>Repurposing therapeutics for COVID-19: Supercomputer-based docking to the SARS-CoV-2 viral spike protein and viral spike protein-human ACE2 interface</article-title><source>ChemRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.26434/chemrxiv.11871402.v4</pub-id></element-citation></ref><ref id="B74-molecules-26-00632"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Raghuvanshi</surname><given-names>R.</given-names></name><name><surname>Ceylan</surname><given-names>F.D.</given-names></name><name><surname>Bolling</surname><given-names>B.W.</given-names></name></person-group><article-title>Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity</article-title><source>J. Agric. Food Chem.</source><year>2020</year><volume>68</volume><fpage>13982</fpage><lpage>13989</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.0c05064</pub-id><?supplied-pmid 33179911?><pub-id pub-id-type="pmid">33179911</pub-id></element-citation></ref><ref id="B75-molecules-26-00632"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oz</surname><given-names>M.</given-names></name><name><surname>Lorke</surname><given-names>D.E.</given-names></name><name><surname>Kabbani</surname><given-names>N.</given-names></name></person-group><article-title>A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor</article-title><source>Pharmacol. Ther.</source><year>2020</year><fpage>107750</fpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2020.107750</pub-id><pub-id pub-id-type="pmid">33275999</pub-id></element-citation></ref><ref id="B76-molecules-26-00632"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arslan</surname><given-names>B.</given-names></name><name><surname>Ergun</surname><given-names>N.U.</given-names></name><name><surname>Topuz</surname><given-names>S.</given-names></name><name><surname>Semerci</surname><given-names>S.Y.</given-names></name><name><surname>Suner</surname><given-names>N.</given-names></name><name><surname>Kocatas</surname><given-names>A.</given-names></name><name><surname>Onal</surname><given-names>H.</given-names></name></person-group><article-title>Synergistic Effect of Quercetin and Vitamin C Against COVID-19: Is a Possible Guard for Front Liners</article-title><source>SSRN Electron. J.</source><year>2020</year><pub-id pub-id-type="doi">10.2139/ssrn.3682517</pub-id></element-citation></ref><ref id="B77-molecules-26-00632"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>A.K.</given-names></name><name><surname>Albalawi</surname><given-names>Y.S.</given-names></name><name><surname>Shora</surname><given-names>H.A.</given-names></name><name><surname>Abdelseed</surname><given-names>H.K.</given-names></name><name><surname>Al-Kattan</surname><given-names>A.N.</given-names></name></person-group><article-title>Effects of quadruple therapy: Zinc, quercetin, bromelain and vitamin C on the clinical outcomes of patients infected with COVID-19</article-title><source>Res. Int. J. Endocrinol. Diabetes</source><year>2020</year><volume>1</volume><fpage>18</fpage><lpage>21</lpage></element-citation></ref><ref id="B78-molecules-26-00632"><label>78.</label><element-citation publication-type="gov"><person-group person-group-type="author"><name><surname>Onal</surname><given-names>H.</given-names></name><name><surname>Semerci</surname><given-names>S.</given-names></name></person-group><article-title>Effect of Quercetin on Prophylaxis and Treatment of COVID-19. 2020. NCT04377789</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/home">https://clinicaltrials.gov/ct2/home</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-12-28">(accessed on 28 December 2020)</date-in-citation></element-citation></ref><ref id="B79-molecules-26-00632"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiskirchen</surname><given-names>S.</given-names></name><name><surname>Weiskirchen</surname><given-names>R.</given-names></name></person-group><article-title>Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy?</article-title><source>Adv. Nutr.</source><year>2016</year><volume>7</volume><fpage>706</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.3945/an.115.011627</pub-id><pub-id pub-id-type="pmid">27422505</pub-id></element-citation></ref><ref id="B80-molecules-26-00632"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahedi</surname><given-names>H.M.</given-names></name><name><surname>Ahmad</surname><given-names>S.</given-names></name><name><surname>Abbasi</surname><given-names>S.W.</given-names></name></person-group><article-title>Stilbene-based natural compounds as promising drug candidates against COVID-19</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1762743</pub-id></element-citation></ref><ref id="B81-molecules-26-00632"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ter Ellen</surname><given-names>B.</given-names></name><name><surname>Kumar</surname><given-names>N.D.</given-names></name><name><surname>Bouma</surname><given-names>E.</given-names></name><name><surname>Troost</surname><given-names>B.</given-names></name><name><surname>van de Pol</surname><given-names>D.</given-names></name><name><surname>van der Ende-Metselaar</surname><given-names>H.</given-names></name><name><surname>Apperloo</surname><given-names>L.</given-names></name><name><surname>van Gosliga</surname><given-names>D.</given-names></name><name><surname>van den Berge</surname><given-names>M.</given-names></name><name><surname>Nawijn</surname><given-names>M.</given-names></name></person-group><article-title>Resveratrol and pterostilbene potently inhibit SARS-CoV-2 infection in vitro</article-title><source>bioRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.09.24.285940</pub-id></element-citation></ref><ref id="B82-molecules-26-00632"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>V.F.</given-names></name><name><surname>Garcia</surname><given-names>M.L.</given-names></name><name><surname>Himmel</surname><given-names>D.</given-names></name><name><surname>Reuben</surname><given-names>J.P.</given-names></name><name><surname>Lam</surname><given-names>Y.K.</given-names></name><name><surname>Pan</surname><given-names>J.X.</given-names></name><name><surname>Han</surname><given-names>G.Q.</given-names></name><name><surname>Kaczorowski</surname><given-names>G.J.</given-names></name></person-group><article-title>Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin</article-title><source>J. Biol. Chem.</source><year>1988</year><volume>263</volume><fpage>2238</fpage><lpage>2244</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)69196-3</pub-id><pub-id pub-id-type="pmid">2448307</pub-id></element-citation></ref><ref id="B83-molecules-26-00632"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heister</surname><given-names>P.M.S.</given-names></name><name><surname>Poston</surname><given-names>R.N.</given-names></name></person-group><article-title>Pharmacological hypothesis: TPC2 antagonist tetrandrine as a potential therapeutic agent for COVID-19</article-title><source>Pharmacol. Res. Perspect.</source><year>2020</year><volume>8</volume><fpage>e00653</fpage><pub-id pub-id-type="doi">10.1002/prp2.653</pub-id><?supplied-pmid 32930523?><pub-id pub-id-type="pmid">32930523</pub-id></element-citation></ref><ref id="B84-molecules-26-00632"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y.F.</given-names></name><name><surname>Wink</surname><given-names>M.</given-names></name></person-group><article-title>Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells</article-title><source>Phytomedicine</source><year>2014</year><volume>21</volume><fpage>1110</fpage><lpage>1119</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2014.04.029</pub-id><?supplied-pmid 24856768?><pub-id pub-id-type="pmid">24856768</pub-id></element-citation></ref><ref id="B85-molecules-26-00632"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lan</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Lou</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Hu</surname><given-names>S.</given-names></name><name><surname>Yao</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Design and synthesis of novel C<sub>14</sub>-urea-tetrandrine derivatives with potent anti-cancer activity</article-title><source>Eur. J. Med. Chem.</source><year>2018</year><volume>143</volume><fpage>1968</fpage><lpage>1980</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2017.11.007</pub-id><?supplied-pmid 29133049?><pub-id pub-id-type="pmid">29133049</pub-id></element-citation></ref><ref id="B86-molecules-26-00632"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leeson</surname><given-names>P.D.</given-names></name><name><surname>Springthorpe</surname><given-names>B.</given-names></name></person-group><article-title>The influence of drug-like concepts on decision-making in medicinal chemistry</article-title><source>Nat. Rev. Drug Discov.</source><year>2007</year><volume>6</volume><fpage>881</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1038/nrd2445</pub-id><?supplied-pmid 17971784?><pub-id pub-id-type="pmid">17971784</pub-id></element-citation></ref><ref id="B87-molecules-26-00632"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>S.</given-names></name><name><surname>Roy</surname><given-names>A.</given-names></name></person-group><article-title>In silico analysis of selected alkaloids against main protease (M<sup>pro</sup>) of SARS-CoV-2</article-title><source>Chem. Biol. Interact.</source><year>2020</year><volume>332</volume><fpage>109309</fpage><pub-id pub-id-type="doi">10.1016/j.cbi.2020.109309</pub-id><pub-id pub-id-type="pmid">33181114</pub-id></element-citation></ref><ref id="B88-molecules-26-00632"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riva</surname><given-names>L.</given-names></name><name><surname>Yuan</surname><given-names>S.</given-names></name><name><surname>Yin</surname><given-names>X.</given-names></name><name><surname>Martin-Sancho</surname><given-names>L.</given-names></name><name><surname>Matsunaga</surname><given-names>N.</given-names></name><name><surname>Pache</surname><given-names>L.</given-names></name><name><surname>Burgstaller-Muehlbacher</surname><given-names>S.</given-names></name><name><surname>De Jesus</surname><given-names>P.D.</given-names></name><name><surname>Teriete</surname><given-names>P.</given-names></name><name><surname>Hull</surname><given-names>M.V.</given-names></name><etal/></person-group><article-title>Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing</article-title><source>Nature</source><year>2020</year><volume>586</volume><fpage>113</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2577-1</pub-id><pub-id pub-id-type="pmid">32707573</pub-id></element-citation></ref><ref id="B89-molecules-26-00632"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muhseen</surname><given-names>Z.T.</given-names></name><name><surname>Hameed</surname><given-names>A.R.</given-names></name><name><surname>Al-Hasani</surname><given-names>H.M.</given-names></name><name><surname>Qamar</surname><given-names>M.T.U.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name></person-group><article-title>Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach</article-title><source>J. Mol. Liq.</source><year>2020</year><volume>320</volume><fpage>114493</fpage><pub-id pub-id-type="doi">10.1016/j.molliq.2020.114493</pub-id><pub-id pub-id-type="pmid">33041407</pub-id></element-citation></ref><ref id="B90-molecules-26-00632"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name></person-group><article-title>Pharmacological perspective: Glycyrrhizin may be an efficacious therapeutic agent for COVID-19</article-title><source>Int. J. Antimicrob. Agents</source><year>2020</year><volume>55</volume><fpage>105995</fpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105995</pub-id><pub-id pub-id-type="pmid">32335281</pub-id></element-citation></ref><ref id="B91-molecules-26-00632"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Alessandro</surname><given-names>S.</given-names></name><name><surname>Scaccabarozzi</surname><given-names>D.</given-names></name><name><surname>Signorini</surname><given-names>L.</given-names></name><name><surname>Perego</surname><given-names>F.</given-names></name><name><surname>Ilboudo</surname><given-names>D.P.</given-names></name><name><surname>Ferrante</surname><given-names>P.</given-names></name><name><surname>Delbue</surname><given-names>S.</given-names></name></person-group><article-title>The Use of Antimalarial Drugs against Viral Infection</article-title><source>Microorganisms</source><year>2020</year><volume>8</volume><elocation-id>85</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms8010085</pub-id></element-citation></ref><ref id="B92-molecules-26-00632"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiter</surname><given-names>C.</given-names></name><name><surname>Fr&#x000f6;hlich</surname><given-names>T.</given-names></name><name><surname>Gruber</surname><given-names>L.</given-names></name><name><surname>Hutterer</surname><given-names>C.</given-names></name><name><surname>Marschall</surname><given-names>M.</given-names></name><name><surname>Voigtl&#x000e4;nder</surname><given-names>C.</given-names></name><name><surname>Friedrich</surname><given-names>O.</given-names></name><name><surname>Kappes</surname><given-names>B.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name><name><surname>Tsogoeva</surname><given-names>S.B.</given-names></name></person-group><article-title>Highly potent artemisinin-derived dimers and trimers: Synthesis and evaluation of their antimalarial, antileukemia and antiviral activities</article-title><source>Bioorg. Med. Chem.</source><year>2015</year><volume>23</volume><fpage>5452</fpage><lpage>5458</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2015.07.048</pub-id><?supplied-pmid 26260339?><pub-id pub-id-type="pmid">26260339</pub-id></element-citation></ref><ref id="B93-molecules-26-00632"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sehailia</surname><given-names>M.</given-names></name><name><surname>Chemat</surname><given-names>S.</given-names></name></person-group><article-title>Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: Potential repurposing of artenimol for COVID-19</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1796809</pub-id><?supplied-pmid 32696720?><pub-id pub-id-type="pmid">32696720</pub-id></element-citation></ref><ref id="B94-molecules-26-00632"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>R.</given-names></name><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Yan</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Anti-SARS-CoV-2 Potential of Artemisinins In Vitro</article-title><source>ACS Infect. Dis.</source><year>2020</year><volume>6</volume><fpage>2524</fpage><lpage>2531</lpage><pub-id pub-id-type="doi">10.1021/acsinfecdis.0c00522</pub-id><?supplied-pmid 32786284?><pub-id pub-id-type="pmid">32786284</pub-id></element-citation></ref><ref id="B95-molecules-26-00632"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slobodnick</surname><given-names>A.</given-names></name><name><surname>Shah</surname><given-names>B.</given-names></name><name><surname>Pillinger</surname><given-names>M.H.</given-names></name><name><surname>Krasnokutsky</surname><given-names>S.</given-names></name></person-group><article-title>Colchicine: Old and new</article-title><source>Am. J. Med.</source><year>2015</year><volume>128</volume><fpage>461</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1016/j.amjmed.2014.12.010</pub-id><?supplied-pmid 25554368?><pub-id pub-id-type="pmid">25554368</pub-id></element-citation></ref><ref id="B96-molecules-26-00632"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>M.</given-names></name><name><surname>Yanagi</surname><given-names>Y.</given-names></name><name><surname>Ichinohe</surname><given-names>T.</given-names></name></person-group><article-title>Encephalomyocarditis Virus Viroporin 2B Activates NLRP3 Inflammasome</article-title><source>PLOS Pathog.</source><year>2012</year><volume>8</volume><elocation-id>e1002857</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002857</pub-id><pub-id pub-id-type="pmid">22916014</pub-id></element-citation></ref><ref id="B97-molecules-26-00632"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>Y.Y.</given-names></name><name><surname>Hui</surname><given-names>L.L.Y.</given-names></name><name><surname>Kraus</surname><given-names>V.B.</given-names></name></person-group><article-title>Colchicine&#x02014;Update on mechanisms of action and therapeutic uses</article-title><source>Semin. Arthritis Rheum.</source><year>2015</year><volume>45</volume><fpage>341</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1016/j.semarthrit.2015.06.013</pub-id><pub-id pub-id-type="pmid">26228647</pub-id></element-citation></ref><ref id="B98-molecules-26-00632"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohag</surname><given-names>A.A.M.</given-names></name><name><surname>Hannan</surname><given-names>A.</given-names></name><name><surname>Rahman</surname><given-names>S.</given-names></name><name><surname>Hossain</surname><given-names>M.</given-names></name><name><surname>Hasan</surname><given-names>M.</given-names></name><name><surname>Khan</surname><given-names>K.</given-names></name><name><surname>Khatun</surname><given-names>A.</given-names></name><name><surname>Dash</surname><given-names>R.</given-names></name><name><surname>Uddin</surname><given-names>J.</given-names></name></person-group><article-title>Revisiting potential druggable targets against SARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review</article-title><source>Drug Dev. Res.</source><year>2020</year><volume>81</volume><fpage>919</fpage><lpage>941</lpage><pub-id pub-id-type="doi">10.1002/ddr.21709</pub-id></element-citation></ref><ref id="B99-molecules-26-00632"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scarsi</surname><given-names>M.</given-names></name><name><surname>Piantoni</surname><given-names>S.</given-names></name><name><surname>Colombo</surname><given-names>E.</given-names></name><name><surname>Air&#x000f3;</surname><given-names>P.</given-names></name><name><surname>Richini</surname><given-names>D.</given-names></name><name><surname>Miclini</surname><given-names>M.</given-names></name><name><surname>Bertasi</surname><given-names>V.</given-names></name><name><surname>Bianchi</surname><given-names>M.</given-names></name><name><surname>Bottone</surname><given-names>D.</given-names></name><name><surname>Civelli</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome</article-title><source>Ann. Rheum. Dis.</source><year>2020</year><volume>79</volume><fpage>1286</fpage><lpage>1289</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2020-217712</pub-id><pub-id pub-id-type="pmid">32732245</pub-id></element-citation></ref><ref id="B100-molecules-26-00632"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gendelman</surname><given-names>O.</given-names></name><name><surname>Amital</surname><given-names>H.</given-names></name><name><surname>Bragazzi</surname><given-names>N.L.</given-names></name><name><surname>Watad</surname><given-names>A.</given-names></name><name><surname>Chodick</surname><given-names>G.</given-names></name></person-group><article-title>Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis</article-title><source>Autoimmun. Rev.</source><year>2020</year><volume>19</volume><fpage>102566</fpage><pub-id pub-id-type="doi">10.1016/j.autrev.2020.102566</pub-id><pub-id pub-id-type="pmid">32380315</pub-id></element-citation></ref><ref id="B101-molecules-26-00632"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocca</surname><given-names>R.</given-names></name><name><surname>Moraca</surname><given-names>F.</given-names></name><name><surname>Costa</surname><given-names>G.</given-names></name><name><surname>Alcaro</surname><given-names>S.</given-names></name><name><surname>Distinto</surname><given-names>S.</given-names></name><name><surname>Maccioni</surname><given-names>E.</given-names></name><name><surname>Ortuso</surname><given-names>F.</given-names></name><name><surname>Artese</surname><given-names>A.</given-names></name><name><surname>Parrotta</surname><given-names>L.</given-names></name></person-group><article-title>Structure-Based Virtual Screening of Novel Natural Alkaloid Derivatives as Potential Binders of <italic>h-telo</italic> and <italic>c-myc</italic> DNA G-Quadruplex Conformations</article-title><source>Molecules</source><year>2014</year><volume>20</volume><fpage>206</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.3390/molecules20010206</pub-id><pub-id pub-id-type="pmid">25547724</pub-id></element-citation></ref><ref id="B102-molecules-26-00632"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moraca</surname><given-names>F.</given-names></name><name><surname>Amato</surname><given-names>J.</given-names></name><name><surname>Ortuso</surname><given-names>F.</given-names></name><name><surname>Artese</surname><given-names>A.</given-names></name><name><surname>Pagano</surname><given-names>B.</given-names></name><name><surname>Novellino</surname><given-names>E.</given-names></name><name><surname>Alcaro</surname><given-names>S.</given-names></name><name><surname>Parrinello</surname><given-names>M.</given-names></name><name><surname>Limongelli</surname><given-names>V.</given-names></name></person-group><article-title>Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2017</year><volume>114</volume><fpage>E2136</fpage><lpage>E2145</lpage><pub-id pub-id-type="doi">10.1073/pnas.1612627114</pub-id><?supplied-pmid 28232513?><pub-id pub-id-type="pmid">28232513</pub-id></element-citation></ref><ref id="B103-molecules-26-00632"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaserer</surname><given-names>T.</given-names></name><name><surname>Rigo</surname><given-names>R.</given-names></name><name><surname>Schuster</surname><given-names>P.</given-names></name><name><surname>Alcaro</surname><given-names>S.</given-names></name><name><surname>Sissi</surname><given-names>C.</given-names></name><name><surname>Schuster</surname><given-names>D.</given-names></name></person-group><article-title>Optimized Virtual Screening Workflow for the Identification of Novel G-Quadruplex Ligands</article-title><source>J. Chem. Inf. Model.</source><year>2016</year><volume>56</volume><fpage>484</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.5b00658</pub-id><?supplied-pmid 26841201?><pub-id pub-id-type="pmid">26841201</pub-id></element-citation></ref><ref id="B104-molecules-26-00632"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varghese</surname><given-names>F.S.</given-names></name><name><surname>Kaukinen</surname><given-names>P.</given-names></name><name><surname>Gl&#x000e4;sker</surname><given-names>S.</given-names></name><name><surname>Bespalov</surname><given-names>M.</given-names></name><name><surname>Hanski</surname><given-names>L.</given-names></name><name><surname>Wennerberg</surname><given-names>K.</given-names></name><name><surname>K&#x000fc;mmerer</surname><given-names>B.M.</given-names></name><name><surname>Ahola</surname><given-names>T.</given-names></name></person-group><article-title>Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses</article-title><source>Antivir. Res.</source><year>2016</year><volume>126</volume><fpage>117</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2015.12.012</pub-id><?supplied-pmid 26752081?><pub-id pub-id-type="pmid">26752081</pub-id></element-citation></ref><ref id="B105-molecules-26-00632"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizzorno</surname><given-names>A.</given-names></name><name><surname>Padey</surname><given-names>B.</given-names></name><name><surname>Dubois</surname><given-names>J.</given-names></name><name><surname>Julien</surname><given-names>T.</given-names></name><name><surname>Traversier</surname><given-names>A.</given-names></name><name><surname>Duli&#x000e8;re</surname><given-names>V.</given-names></name><name><surname>Brun</surname><given-names>P.</given-names></name><name><surname>Lina</surname><given-names>B.</given-names></name><name><surname>Rosa-Calatrava</surname><given-names>M.</given-names></name><name><surname>Terrier</surname><given-names>O.</given-names></name></person-group><article-title>In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2</article-title><source>Antivir. Res.</source><year>2020</year><volume>181</volume><fpage>104878</fpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2020.104878</pub-id><?supplied-pmid 32679055?><pub-id pub-id-type="pmid">32679055</pub-id></element-citation></ref><ref id="B106-molecules-26-00632"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Cao</surname><given-names>K.</given-names></name><name><surname>You</surname><given-names>Y.</given-names></name><name><surname>Qian</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>W.</given-names></name></person-group><article-title>Berberine reduces circulating inflammatory mediators in patients with severe COVID-19</article-title><source>Br. J. Surg.</source><year>2020</year><pub-id pub-id-type="doi">10.1093/bjs/znaa021</pub-id></element-citation></ref><ref id="B107-molecules-26-00632"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varghese</surname><given-names>F.S.</given-names></name><name><surname>van Woudenbergh</surname><given-names>E.</given-names></name><name><surname>Overheul</surname><given-names>G.J.</given-names></name><name><surname>Eleveld</surname><given-names>M.J.</given-names></name><name><surname>Kurver</surname><given-names>L.</given-names></name><name><surname>van Heerbeek</surname><given-names>N.</given-names></name><name><surname>van Laarhoven</surname><given-names>A.</given-names></name><name><surname>Miesen</surname><given-names>P.</given-names></name><name><surname>den Hartog</surname><given-names>G.</given-names></name><name><surname>de Jonge</surname><given-names>M.I.</given-names></name></person-group><article-title>Berberine and obatoclax inhibit SARS-CoV-2 replication in primary human nasal epithelial cells in vitro</article-title><source>bioRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.12.23.424189</pub-id></element-citation></ref><ref id="B108-molecules-26-00632"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krupanidhi</surname><given-names>S.</given-names></name><name><surname>Abraham Peele</surname><given-names>K.</given-names></name><name><surname>Venkateswarulu</surname><given-names>T.</given-names></name><name><surname>Ayyagari</surname><given-names>V.S.</given-names></name><name><surname>Nazneen Bobby</surname><given-names>M.</given-names></name><name><surname>John Babu</surname><given-names>D.</given-names></name><name><surname>Venkata Narayana</surname><given-names>A.</given-names></name><name><surname>Aishwarya</surname><given-names>G.</given-names></name></person-group><article-title>Screening of phytochemical compounds of <italic>Tinospora cordifolia</italic> for their inhibitory activity on SARS-CoV-2: An in silico study</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1787226</pub-id></element-citation></ref><ref id="B109-molecules-26-00632"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debnath</surname><given-names>B.</given-names></name><name><surname>Singh</surname><given-names>W.S.</given-names></name><name><surname>Das</surname><given-names>M.</given-names></name><name><surname>Goswami</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>M.K.</given-names></name><name><surname>Maiti</surname><given-names>D.</given-names></name><name><surname>Manna</surname><given-names>K.</given-names></name></person-group><article-title>Role of plant alkaloids on human health: A review of biological activities</article-title><source>Mater. Today Chem.</source><year>2018</year><volume>9</volume><fpage>56</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.mtchem.2018.05.001</pub-id></element-citation></ref><ref id="B110-molecules-26-00632"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borquaye</surname><given-names>L.S.</given-names></name><name><surname>Gasu</surname><given-names>E.N.</given-names></name><name><surname>Ampomah</surname><given-names>G.B.</given-names></name><name><surname>Kyei</surname><given-names>L.K.</given-names></name><name><surname>Amarh</surname><given-names>M.A.</given-names></name><name><surname>Mensah</surname><given-names>C.N.</given-names></name><name><surname>Nartey</surname><given-names>D.</given-names></name><name><surname>Commodore</surname><given-names>M.</given-names></name><name><surname>Adomako</surname><given-names>A.K.</given-names></name><name><surname>Acheampong</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Alkaloids from <italic>Cryptolepis sanguinolenta</italic> as Potential Inhibitors of SARS-CoV-2 Viral Proteins: An In Silico Study</article-title><source>BioMed Res. Int.</source><year>2020</year><volume>2020</volume><fpage>5324560</fpage><pub-id pub-id-type="doi">10.1155/2020/5324560</pub-id><pub-id pub-id-type="pmid">33029513</pub-id></element-citation></ref><ref id="B111-molecules-26-00632"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyebi</surname><given-names>G.A.</given-names></name><name><surname>Adegunloye</surname><given-names>A.P.</given-names></name><name><surname>Ibrahim</surname><given-names>I.M.</given-names></name><name><surname>Ogunyemi</surname><given-names>O.M.</given-names></name><name><surname>Afolabi</surname><given-names>S.O.</given-names></name><name><surname>Ogunro</surname><given-names>O.B.</given-names></name></person-group><article-title>Prevention of SARS-CoV-2 cell entry: Insight from in silico interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1835726</pub-id></element-citation></ref><ref id="B112-molecules-26-00632"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfaro</surname><given-names>M.</given-names></name><name><surname>Alfaro</surname><given-names>I.</given-names></name><name><surname>Angel</surname><given-names>C.</given-names></name></person-group><article-title>Identification of potential inhibitors of SARS-CoV-2 papain-like protease from tropane alkaloids from Schizanthus porrigens: A molecular docking study</article-title><source>Chem. Phys. Lett.</source><year>2020</year><volume>761</volume><fpage>138068</fpage><pub-id pub-id-type="doi">10.1016/j.cplett.2020.138068</pub-id><?supplied-pmid 33052144?><pub-id pub-id-type="pmid">33052144</pub-id></element-citation></ref><ref id="B113-molecules-26-00632"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>R.</given-names></name><name><surname>Chakraborty</surname><given-names>A.</given-names></name><name><surname>Biswas</surname><given-names>A.</given-names></name><name><surname>Chowdhuri</surname><given-names>S.</given-names></name></person-group><article-title>Identification of alkaloids from <italic>Justicia adhatoda</italic> as potent SARS CoV-2 main protease inhibitors: An in silico perspective</article-title><source>J. Mol. Struct.</source><year>2020</year><fpage>129489</fpage><pub-id pub-id-type="doi">10.1016/j.molstruc.2020.129489</pub-id><?supplied-pmid 33100380?><pub-id pub-id-type="pmid">33100380</pub-id></element-citation></ref><ref id="B114-molecules-26-00632"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quimque</surname><given-names>M.T.J.</given-names></name><name><surname>Notarte</surname><given-names>K.I.R.</given-names></name><name><surname>Fernandez</surname><given-names>R.A.T.</given-names></name><name><surname>Mendoza</surname><given-names>M.A.O.</given-names></name><name><surname>Liman</surname><given-names>R.A.D.</given-names></name><name><surname>Lim</surname><given-names>J.A.K.</given-names></name><name><surname>Pilapil</surname><given-names>L.A.E.</given-names></name><name><surname>Ong</surname><given-names>J.K.H.</given-names></name><name><surname>Pastrana</surname><given-names>A.M.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1776639</pub-id><?supplied-pmid 32476574?><pub-id pub-id-type="pmid">32476574</pub-id></element-citation></ref><ref id="B115-molecules-26-00632"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diniz</surname><given-names>L.R.L.</given-names></name><name><surname>P&#x000e9;rez-Castillo</surname><given-names>Y.</given-names></name><name><surname>Elshabrawy</surname><given-names>H.A.</given-names></name><name><surname>Filho</surname><given-names>C.D.S.M.B.</given-names></name><name><surname>De Sousa</surname><given-names>D.P.</given-names></name></person-group><article-title>Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies</article-title><source>Biomolecules</source><year>2021</year><volume>11</volume><elocation-id>74</elocation-id><pub-id pub-id-type="doi">10.3390/biom11010074</pub-id><?supplied-pmid 33430299?><pub-id pub-id-type="pmid">33430299</pub-id></element-citation></ref><ref id="B116-molecules-26-00632"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sepay</surname><given-names>N.</given-names></name><name><surname>Sekar</surname><given-names>A.</given-names></name><name><surname>Halder</surname><given-names>U.C.</given-names></name><name><surname>Alarifi</surname><given-names>A.</given-names></name><name><surname>Afzal</surname><given-names>M.</given-names></name></person-group><article-title>Anti-COVID-19 terpenoid from marine sources: A docking, admet and molecular dynamics study</article-title><source>J. Mol. Struct.</source><year>2021</year><volume>1228</volume><fpage>129433</fpage><pub-id pub-id-type="doi">10.1016/j.molstruc.2020.129433</pub-id><?supplied-pmid 33071352?><pub-id pub-id-type="pmid">33071352</pub-id></element-citation></ref><ref id="B117-molecules-26-00632"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiyama</surname><given-names>R.</given-names></name></person-group><article-title>Estrogenic terpenes and terpenoids: Pathways, functions and applications</article-title><source>Eur. J. Pharmacol.</source><year>2017</year><volume>815</volume><fpage>405</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2017.09.049</pub-id><pub-id pub-id-type="pmid">28970013</pub-id></element-citation></ref><ref id="B118-molecules-26-00632"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gershenzon</surname><given-names>J.</given-names></name><name><surname>Dudareva</surname><given-names>N.</given-names></name></person-group><article-title>The function of terpene natural products in the natural world</article-title><source>Nat. Chem. Biol.</source><year>2007</year><volume>3</volume><fpage>408</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2007.5</pub-id><pub-id pub-id-type="pmid">17576428</pub-id></element-citation></ref><ref id="B119-molecules-26-00632"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>K.J.S.</given-names></name><name><surname>Vani</surname><given-names>M.G.</given-names></name><name><surname>Wang</surname><given-names>C.-S.</given-names></name><name><surname>Chen</surname><given-names>C.-C.</given-names></name><name><surname>Chen</surname><given-names>Y.-C.</given-names></name><name><surname>Lu</surname><given-names>L.-P.</given-names></name><name><surname>Huang</surname><given-names>C.-H.</given-names></name><name><surname>Lai</surname><given-names>C.-S.</given-names></name><name><surname>Wang</surname><given-names>S.-Y.</given-names></name></person-group><article-title>Geranium and Lemon Essential Oils and Their Active Compounds Downregulate Angiotensin-Converting Enzyme 2 (ACE2), a SARS-CoV-2 Spike Receptor-Binding Domain, in Epithelial Cells</article-title><source>Plants</source><year>2020</year><volume>9</volume><elocation-id>770</elocation-id><pub-id pub-id-type="doi">10.3390/plants9060770</pub-id></element-citation></ref><ref id="B120-molecules-26-00632"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulkarni</surname><given-names>S.A.</given-names></name><name><surname>Nagarajan</surname><given-names>S.K.</given-names></name><name><surname>Ramesh</surname><given-names>V.</given-names></name><name><surname>Palaniyandi</surname><given-names>V.</given-names></name><name><surname>Sellamuthu</surname><given-names>P.S.</given-names></name><name><surname>Madhavan</surname><given-names>T.</given-names></name></person-group><article-title>Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein</article-title><source>J. Mol. Struct.</source><year>2020</year><volume>1221</volume><fpage>128823</fpage><pub-id pub-id-type="doi">10.1016/j.molstruc.2020.128823</pub-id><pub-id pub-id-type="pmid">32834111</pub-id></element-citation></ref><ref id="B121-molecules-26-00632"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vardhan</surname><given-names>S.</given-names></name><name><surname>Sahoo</surname><given-names>S.K.</given-names></name></person-group><article-title>Searching inhibitors for three important proteins of COVID-19 through molecular docking studies</article-title><source>arXiv</source><year>2020</year><pub-id pub-id-type="arxiv">2004.08095</pub-id></element-citation></ref><ref id="B122-molecules-26-00632"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carino</surname><given-names>A.</given-names></name><name><surname>Moraca</surname><given-names>F.</given-names></name><name><surname>Fiorillo</surname><given-names>B.</given-names></name><name><surname>Marchian&#x000f2;</surname><given-names>S.</given-names></name><name><surname>Sepe</surname><given-names>V.</given-names></name><name><surname>Biagioli</surname><given-names>M.</given-names></name><name><surname>Finamore</surname><given-names>C.</given-names></name><name><surname>Bozza</surname><given-names>S.</given-names></name><name><surname>Francisci</surname><given-names>D.</given-names></name><name><surname>Distrutti</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain</article-title><source>Front. Chem.</source><year>2020</year><volume>8</volume><fpage>572885</fpage><pub-id pub-id-type="doi">10.3389/fchem.2020.572885</pub-id><?supplied-pmid 33195060?><pub-id pub-id-type="pmid">33195060</pub-id></element-citation></ref><ref id="B123-molecules-26-00632"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Florez</surname><given-names>H.</given-names></name></person-group><article-title>Bioinformatic study to discover natural molecules with activity against COVID-19</article-title><source>F1000Research</source><year>2020</year><volume>9</volume><fpage>1203</fpage><pub-id pub-id-type="doi">10.12688/f1000research.26731.1</pub-id><?supplied-pmid 33145015?><pub-id pub-id-type="pmid">33145015</pub-id></element-citation></ref><ref id="B124-molecules-26-00632"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Choudhir</surname><given-names>G.</given-names></name><name><surname>Shukla</surname><given-names>S.K.</given-names></name><name><surname>Sharma</surname><given-names>M.</given-names></name><name><surname>Tyagi</surname><given-names>P.</given-names></name><name><surname>Bhushan</surname><given-names>A.</given-names></name><name><surname>Rathore</surname><given-names>M.</given-names></name></person-group><article-title>Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1772112</pub-id><?supplied-pmid 32448034?><pub-id pub-id-type="pmid">32448034</pub-id></element-citation></ref><ref id="B125-molecules-26-00632"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poochi</surname><given-names>S.P.</given-names></name><name><surname>Easwaran</surname><given-names>M.</given-names></name><name><surname>Balasubramanian</surname><given-names>B.</given-names></name><name><surname>Anbuselvam</surname><given-names>M.</given-names></name><name><surname>Meyyazhagan</surname><given-names>A.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Bhotla</surname><given-names>H.K.</given-names></name><name><surname>Anbuselvam</surname><given-names>J.</given-names></name><name><surname>Arumugam</surname><given-names>V.A.</given-names></name><name><surname>Keshavarao</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Employing bioactive compounds derived from <italic>Ipomoea obscura</italic> (L.) to evaluate potential inhibitor for SARS-CoV-2 main protease and ACE2 protein</article-title><source>Food Front.</source><year>2020</year><volume>1</volume><fpage>168</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1002/fft2.29</pub-id><?supplied-pmid 32838301?><pub-id pub-id-type="pmid">32838301</pub-id></element-citation></ref><ref id="B126-molecules-26-00632"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>M.K.</given-names></name><name><surname>Singh</surname><given-names>P.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>T.P.</given-names></name><name><surname>Ethayathulla</surname><given-names>A.S.</given-names></name><name><surname>Kaur</surname><given-names>P.</given-names></name></person-group><article-title>Identification of bioactive molecule from <italic>Withania somnifera</italic> (Ashwagandha) as SARS-CoV-2 main protease inhibitor</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1790425</pub-id><?supplied-pmid 32643552?><pub-id pub-id-type="pmid">32643552</pub-id></element-citation></ref><ref id="B127-molecules-26-00632"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chikhale</surname><given-names>R.V.</given-names></name><name><surname>Gurav</surname><given-names>S.S.</given-names></name><name><surname>Patil</surname><given-names>R.B.</given-names></name><name><surname>Sinha</surname><given-names>S.K.</given-names></name><name><surname>Prasad</surname><given-names>S.</given-names></name><name><surname>Shakya</surname><given-names>A.</given-names></name><name><surname>Shrivastava</surname><given-names>S.K.</given-names></name><name><surname>Gurav</surname><given-names>N.</given-names></name><name><surname>Prasad</surname><given-names>R.S.</given-names></name></person-group><article-title>Sars-cov-2 host entry and replication inhibitors from Indian ginseng: An in-silico approach</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1778539</pub-id><?supplied-pmid 32568012?><pub-id pub-id-type="pmid">32568012</pub-id></element-citation></ref><ref id="B128-molecules-26-00632"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddiqui</surname><given-names>S.</given-names></name><name><surname>Upadhyay</surname><given-names>S.</given-names></name><name><surname>Ahmad</surname><given-names>R.</given-names></name><name><surname>Gupta</surname><given-names>A.</given-names></name><name><surname>Srivastava</surname><given-names>A.</given-names></name><name><surname>Trivedi</surname><given-names>A.</given-names></name><name><surname>Husain</surname><given-names>I.</given-names></name><name><surname>Ahmad</surname><given-names>B.</given-names></name><name><surname>Ahamed</surname><given-names>M.</given-names></name><name><surname>Khan</surname><given-names>M.A.</given-names></name></person-group><article-title>Virtual screening of phytoconstituents from miracle herb <italic>nigella sativa</italic> targeting nucleocapsid protein and papain-like protease of SARS-CoV-2 for COVID-19 treatment</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1852117</pub-id></element-citation></ref><ref id="B129-molecules-26-00632"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gidaro</surname><given-names>M.C.</given-names></name><name><surname>Astorino</surname><given-names>C.</given-names></name><name><surname>Petzer</surname><given-names>A.</given-names></name><name><surname>Carradori</surname><given-names>S.</given-names></name><name><surname>Alcaro</surname><given-names>F.</given-names></name><name><surname>Costa</surname><given-names>G.</given-names></name><name><surname>Artese</surname><given-names>A.</given-names></name><name><surname>Rafele</surname><given-names>G.</given-names></name><name><surname>Russo</surname><given-names>F.M.</given-names></name><name><surname>Petzer</surname><given-names>J.P.</given-names></name><etal/></person-group><article-title>Kaempferol as Selective Human MAO-A Inhibitor: Analytical Detection in Calabrian Red Wines, Biological and Molecular Modeling Studies</article-title><source>J. Agric. Food Chem.</source><year>2016</year><volume>64</volume><fpage>1394</fpage><lpage>1400</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.5b06043</pub-id><pub-id pub-id-type="pmid">26821152</pub-id></element-citation></ref><ref id="B130-molecules-26-00632"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carradori</surname><given-names>S.</given-names></name><name><surname>Gidaro</surname><given-names>M.C.</given-names></name><name><surname>Petzer</surname><given-names>A.</given-names></name><name><surname>Costa</surname><given-names>G.</given-names></name><name><surname>Guglielmi</surname><given-names>P.</given-names></name><name><surname>Chimenti</surname><given-names>P.</given-names></name><name><surname>Alcaro</surname><given-names>S.</given-names></name><name><surname>Petzer</surname><given-names>J.P.</given-names></name></person-group><article-title>Inhibition of Human Monoamine Oxidase: Biological and Molecular Modeling Studies on Selected Natural Flavonoids</article-title><source>J. Agric. Food Chem.</source><year>2016</year><volume>64</volume><fpage>9004</fpage><lpage>9011</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.6b03529</pub-id><pub-id pub-id-type="pmid">27933876</pub-id></element-citation></ref><ref id="B131-molecules-26-00632"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qamar</surname><given-names>M.T.U.</given-names></name><name><surname>Alqahtani</surname><given-names>S.M.</given-names></name><name><surname>Alamri</surname><given-names>M.A.</given-names></name><name><surname>Chen</surname><given-names>L.-L.</given-names></name></person-group><article-title>Structural basis of SARS-CoV-2 3CL<sup>pro</sup> and anti-COVID-19 drug discovery from medicinal plants</article-title><source>J. Pharm. Anal.</source><year>2020</year><volume>10</volume><fpage>313</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1016/j.jpha.2020.03.009</pub-id><pub-id pub-id-type="pmid">32296570</pub-id></element-citation></ref><ref id="B132-molecules-26-00632"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>D.</given-names></name><name><surname>Debnath</surname><given-names>P.</given-names></name><name><surname>Debnath</surname><given-names>B.</given-names></name><name><surname>Bhaumik</surname><given-names>S.</given-names></name><name><surname>Debnath</surname><given-names>S.</given-names></name></person-group><article-title>Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1819883</pub-id><?supplied-pmid 32948116?><pub-id pub-id-type="pmid">32948116</pub-id></element-citation></ref><ref id="B133-molecules-26-00632"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherrak</surname><given-names>S.A.</given-names></name><name><surname>Merzouk</surname><given-names>H.</given-names></name><name><surname>Mokhtari-Soulimane</surname><given-names>N.</given-names></name></person-group><article-title>Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><elocation-id>e0240653</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0240653</pub-id><?supplied-pmid 33057452?><pub-id pub-id-type="pmid">33057452</pub-id></element-citation></ref><ref id="B134-molecules-26-00632"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J.-Y.</given-names></name><name><surname>Yuk</surname><given-names>H.J.</given-names></name><name><surname>Ryu</surname><given-names>H.W.</given-names></name><name><surname>Lim</surname><given-names>S.H.</given-names></name><name><surname>Kim</surname><given-names>K.S.</given-names></name><name><surname>Park</surname><given-names>K.H.</given-names></name><name><surname>Ryu</surname><given-names>Y.B.</given-names></name><name><surname>Lee</surname><given-names>W.S.</given-names></name></person-group><article-title>Evaluation of polyphenols from <italic>Broussonetia papyrifera</italic> as coronavirus protease inhibitors</article-title><source>J. Enzym. Inhib. Med. Chem.</source><year>2017</year><volume>32</volume><fpage>504</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1080/14756366.2016.1265519</pub-id><?supplied-pmid 28112000?><pub-id pub-id-type="pmid">28112000</pub-id></element-citation></ref><ref id="B135-molecules-26-00632"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>D.Y.</given-names></name><name><surname>Kim</surname><given-names>M.-S.</given-names></name><name><surname>Shin</surname><given-names>D.H.</given-names></name></person-group><article-title>Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro</article-title><source>J. Enzym. Inhib. Med. Chem.</source><year>2020</year><volume>35</volume><fpage>1539</fpage><lpage>1544</lpage><pub-id pub-id-type="doi">10.1080/14756366.2020.1801672</pub-id></element-citation></ref><ref id="B136-molecules-26-00632"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Liew</surname><given-names>O.W.</given-names></name><name><surname>Zhu</surname><given-names>W.</given-names></name><name><surname>Puah</surname><given-names>C.</given-names></name><name><surname>Shen</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Binding interaction of quercetin-3-&#x003b2;-galactoside and its synthetic derivatives with SARS-CoV 3CL<sup>pro</sup>: Structure-activity relationship studies reveal salient pharmacophore features</article-title><source>Bioorg. Med. Chem.</source><year>2006</year><volume>14</volume><fpage>8295</fpage><lpage>8306</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2006.09.014</pub-id><pub-id pub-id-type="pmid">17046271</pub-id></element-citation></ref><ref id="B137-molecules-26-00632"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahlan</surname><given-names>M.</given-names></name><name><surname>Irdiani</surname><given-names>R.</given-names></name><name><surname>Flamandita</surname><given-names>D.</given-names></name><name><surname>Aditama</surname><given-names>R.</given-names></name><name><surname>Alfarraj</surname><given-names>S.</given-names></name><name><surname>Ansari</surname><given-names>M.J.</given-names></name><name><surname>Khayrani</surname><given-names>A.C.</given-names></name><name><surname>Pratami</surname><given-names>D.K.</given-names></name><name><surname>Lischer</surname><given-names>K.</given-names></name></person-group><article-title>Molecular interaction analysis of Sulawesi propolis compounds with SARS-CoV-2 main protease as preliminary study for COVID-19 drug discovery</article-title><source>J. King Saud Univ. Sci.</source><year>2021</year><volume>33</volume><fpage>101234</fpage><pub-id pub-id-type="doi">10.1016/j.jksus.2020.101234</pub-id><pub-id pub-id-type="pmid">33223766</pub-id></element-citation></ref><ref id="B138-molecules-26-00632"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muchtaridi</surname><given-names>M.</given-names></name><name><surname>Fauzi</surname><given-names>M.</given-names></name><name><surname>Ikram</surname><given-names>N.K.K.</given-names></name><name><surname>Gazzali</surname><given-names>A.M.</given-names></name><name><surname>Wahab</surname><given-names>H.A.</given-names></name></person-group><article-title>Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>3980</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25173980</pub-id></element-citation></ref><ref id="B139-molecules-26-00632"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000fc;ler</surname><given-names>H.I.</given-names></name><name><surname>Tatar</surname><given-names>G.</given-names></name><name><surname>Yildiz</surname><given-names>O.</given-names></name><name><surname>Belduz</surname><given-names>A.O.</given-names></name><name><surname>Kolayli</surname><given-names>S.</given-names></name></person-group><article-title>An investigation of ethanolic propolis extracts: Their potential inhibitor properties against ACE-II receptors for COVID-19 treatment by Molecular Docking Study</article-title><source>ScienceOpen Prepr.</source><year>2020</year><pub-id pub-id-type="doi">10.14293/S2199-1006.1.SOR-.PP5BWN4.v1</pub-id></element-citation></ref><ref id="B140-molecules-26-00632"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A.S.</given-names></name><name><surname>Ackerley</surname><given-names>D.F.</given-names></name><name><surname>Calcott</surname><given-names>M.J.</given-names></name></person-group><article-title>High-Throughput Screening for Inhibitors of the SARS-CoV-2 Protease Using a FRET-Biosensor</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>4666</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25204666</pub-id></element-citation></ref><ref id="B141-molecules-26-00632"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seadawy</surname><given-names>M.G.</given-names></name><name><surname>Gad</surname><given-names>A.F.</given-names></name><name><surname>Shamel</surname><given-names>M.</given-names></name><name><surname>Elharty</surname><given-names>B.</given-names></name><name><surname>Mohamed</surname><given-names>M.F.</given-names></name><name><surname>Elfiky</surname><given-names>A.A.</given-names></name><name><surname>Ahmed</surname><given-names>A.</given-names></name><name><surname>Zekri</surname><given-names>A.R.N.</given-names></name></person-group><article-title>In vitro: Natural Compounds (Thymol, Carvacrol, Hesperidine, and Thymoquinone) against SARS-CoV2 Strain Isolated From Egyptian Patients</article-title><source>bioRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.11.07.367649</pub-id></element-citation></ref><ref id="B142-molecules-26-00632"><label>142.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>R.</given-names></name></person-group><source>Naturally Occurring Quinones</source><publisher-name>Academic Press</publisher-name><publisher-loc>London, UK</publisher-loc><year>2012</year></element-citation></ref><ref id="B143-molecules-26-00632"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shuveksh</surname><given-names>K.A.P.S.</given-names></name><name><surname>Ahmed</surname><given-names>K.</given-names></name><name><surname>Padhye</surname><given-names>S.</given-names></name><name><surname>Schobert</surname><given-names>R.</given-names></name><name><surname>Biersack</surname><given-names>B.</given-names></name></person-group><article-title>Chemical and Biological Aspects of the Natural 1,4-Benzoquinone Embelin and its (semi-)Synthetic Derivatives</article-title><source>Curr. Med. Chem.</source><year>2017</year><volume>24</volume><fpage>1998</fpage><lpage>2009</lpage><pub-id pub-id-type="doi">10.2174/0929867324666170116125731</pub-id><?supplied-pmid 28093981?><pub-id pub-id-type="pmid">28093981</pub-id></element-citation></ref><ref id="B144-molecules-26-00632"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radhakrishnan</surname><given-names>N.</given-names></name><name><surname>Gnanamani</surname><given-names>A.</given-names></name></person-group><article-title>2,5-dihydroxy-3-undecyl-1, 4-benzoquinone (Embelin)-A second solid gold of India-A Review</article-title><source>Int. J. Pharm. Pharm. Sci.</source><year>2014</year><volume>6</volume><fpage>23</fpage><lpage>30</lpage></element-citation></ref><ref id="B145-molecules-26-00632"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bittner</surname><given-names>S.</given-names></name></person-group><article-title>When quinones meet amino acids: Chemical, physical and biological consequences</article-title><source>Amino Acids</source><year>2006</year><volume>30</volume><fpage>205</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1007/s00726-005-0298-2</pub-id><?supplied-pmid 16601927?><pub-id pub-id-type="pmid">16601927</pub-id></element-citation></ref><ref id="B146-molecules-26-00632"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caruso</surname><given-names>F.</given-names></name><name><surname>Rossi</surname><given-names>M.</given-names></name><name><surname>Pedersen</surname><given-names>J.Z.</given-names></name><name><surname>Incerpi</surname><given-names>S.</given-names></name></person-group><article-title>Computational studies reveal mechanism by which quinone derivatives can inhibit SARS-CoV-2. Study of embelin and two therapeutic compounds of interest, methyl prednisolone and dexamethasone</article-title><source>J. Infect. Public Health</source><year>2020</year><volume>13</volume><pub-id pub-id-type="doi">10.1016/j.jiph.2020.09.015</pub-id><?supplied-pmid 33109497?><pub-id pub-id-type="pmid">33109497</pub-id></element-citation></ref><ref id="B147-molecules-26-00632"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basu</surname><given-names>A.</given-names></name><name><surname>Sarkar</surname><given-names>A.</given-names></name><name><surname>Maulik</surname><given-names>U.</given-names></name></person-group><article-title>Computational approach for the design of potential spike protein binding natural compounds in SARS-CoV2</article-title><source>Pharmacodynamics</source><year>2020</year><pub-id pub-id-type="doi">10.21203/rs.3.rs-33181/v1</pub-id></element-citation></ref><ref id="B148-molecules-26-00632"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>T.-Y.</given-names></name><name><surname>Wu</surname><given-names>S.-L.</given-names></name><name><surname>Chen</surname><given-names>J.-C.</given-names></name><name><surname>Li</surname><given-names>C.-C.</given-names></name><name><surname>Hsiang</surname><given-names>C.-Y.</given-names></name></person-group><article-title>Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction</article-title><source>Antivir. Res.</source><year>2007</year><volume>74</volume><fpage>92</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2006.04.014</pub-id><pub-id pub-id-type="pmid">16730806</pub-id></element-citation></ref><ref id="B149-molecules-26-00632"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thuy</surname><given-names>B.T.P.</given-names></name><name><surname>My</surname><given-names>T.T.A.</given-names></name><name><surname>Hai</surname><given-names>N.T.T.</given-names></name><name><surname>Hieu</surname><given-names>L.T.</given-names></name><name><surname>Hoa</surname><given-names>T.T.</given-names></name><name><surname>Loan</surname><given-names>H.T.P.</given-names></name><name><surname>Triet</surname><given-names>N.T.</given-names></name><name><surname>Van Anh</surname><given-names>T.T.</given-names></name><name><surname>Quy</surname><given-names>P.T.</given-names></name><name><surname>Van Tat</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil</article-title><source>ACS Omega</source><year>2020</year><volume>5</volume><fpage>8312</fpage><lpage>8320</lpage><pub-id pub-id-type="doi">10.1021/acsomega.0c00772</pub-id><pub-id pub-id-type="pmid">32363255</pub-id></element-citation></ref><ref id="B150-molecules-26-00632"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>My</surname><given-names>T.T.A.</given-names></name><name><surname>Loan</surname><given-names>H.T.P.</given-names></name><name><surname>Hai</surname><given-names>N.T.T.</given-names></name><name><surname>Hieu</surname><given-names>L.T.</given-names></name><name><surname>Hoa</surname><given-names>T.T.</given-names></name><name><surname>Thuy</surname><given-names>B.T.P.</given-names></name><name><surname>Quang</surname><given-names>D.T.</given-names></name><name><surname>Triet</surname><given-names>N.T.</given-names></name><name><surname>Van Anh</surname><given-names>T.T.</given-names></name><name><surname>Dieu</surname><given-names>N.T.X.</given-names></name><etal/></person-group><article-title>Evaluation of the Inhibitory Activities of COVID-19 of <italic>Melaleuca cajuputi</italic> Oil Using Docking Simulation</article-title><source>ChemistrySelect</source><year>2020</year><volume>5</volume><fpage>6312</fpage><lpage>6320</lpage><pub-id pub-id-type="doi">10.1002/slct.202000822</pub-id><pub-id pub-id-type="pmid">32572383</pub-id></element-citation></ref><ref id="B151-molecules-26-00632"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaldam</surname><given-names>M.A.</given-names></name><name><surname>Yahya</surname><given-names>G.</given-names></name><name><surname>Mohamed</surname><given-names>N.H.</given-names></name><name><surname>Abdel-Daim</surname><given-names>M.M.</given-names></name><name><surname>Al Naggar</surname><given-names>Y.</given-names></name></person-group><article-title>In silico screening of potent bioactive compounds from honey bee products against COVID-19 target enzymes</article-title><source>ChemRxiv Prepr.</source><year>2020</year><pub-id pub-id-type="doi">10.26434/chemrxiv.12644102.v1</pub-id></element-citation></ref><ref id="B152-molecules-26-00632"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poduri</surname><given-names>R.</given-names></name><name><surname>Joshi</surname><given-names>G.</given-names></name><name><surname>Jagadeesh</surname><given-names>G.</given-names></name></person-group><article-title>Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19</article-title><source>Cell. Signal.</source><year>2020</year><volume>74</volume><fpage>109721</fpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2020.109721</pub-id><pub-id pub-id-type="pmid">32711111</pub-id></element-citation></ref><ref id="B153-molecules-26-00632"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peele</surname><given-names>K.A.</given-names></name><name><surname>Chandrasai</surname><given-names>P.</given-names></name><name><surname>Srihansa</surname><given-names>T.</given-names></name><name><surname>Krupanidhi</surname><given-names>S.</given-names></name><name><surname>Sai</surname><given-names>A.V.</given-names></name><name><surname>Babu</surname><given-names>D.J.</given-names></name><name><surname>Indira</surname><given-names>M.</given-names></name><name><surname>Reddy</surname><given-names>A.R.</given-names></name><name><surname>Venkateswarulu</surname><given-names>T.</given-names></name></person-group><article-title>Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study</article-title><source>Inform. Med. Unlocked</source><year>2020</year><volume>19</volume><fpage>100345</fpage><pub-id pub-id-type="doi">10.1016/j.imu.2020.100345</pub-id><?supplied-pmid 32395606?><pub-id pub-id-type="pmid">32395606</pub-id></element-citation></ref><ref id="B154-molecules-26-00632"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>S.</given-names></name><name><surname>Twilley</surname><given-names>D.</given-names></name><name><surname>Esmear</surname><given-names>T.</given-names></name><name><surname>Oosthuizen</surname><given-names>C.B.</given-names></name><name><surname>Reid</surname><given-names>A.-M.</given-names></name><name><surname>Nel</surname><given-names>M.</given-names></name><name><surname>Lall</surname><given-names>N.</given-names></name></person-group><article-title>Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)</article-title><source>Front. Pharmacol.</source><year>2020</year><volume>11</volume><fpage>561334</fpage><pub-id pub-id-type="doi">10.3389/fphar.2020.561334</pub-id><?supplied-pmid 33101023?><pub-id pub-id-type="pmid">33101023</pub-id></element-citation></ref><ref id="B155-molecules-26-00632"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyebi</surname><given-names>G.A.</given-names></name><name><surname>Ogunro</surname><given-names>O.B.</given-names></name><name><surname>Adegunloye</surname><given-names>A.P.</given-names></name><name><surname>Ogunyemi</surname><given-names>O.M.</given-names></name><name><surname>Afolabi</surname><given-names>S.O.</given-names></name></person-group><article-title>Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CL<sup>pro</sup>): An in silico screening of alkaloids and terpenoids from African medicinal plants</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1764868</pub-id><?supplied-pmid 32367767?><pub-id pub-id-type="pmid">32367767</pub-id></element-citation></ref><ref id="B156-molecules-26-00632"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Bartlam</surname><given-names>M.</given-names></name><name><surname>Rao</surname><given-names>Z.</given-names></name></person-group><article-title>Drug Design Targeting the Main Protease, the Achilles Heel of Coronaviruses</article-title><source>Curr. Pharm. Des.</source><year>2006</year><volume>12</volume><fpage>4573</fpage><lpage>4590</lpage><pub-id pub-id-type="doi">10.2174/138161206779010369</pub-id><?supplied-pmid 17168763?><pub-id pub-id-type="pmid">17168763</pub-id></element-citation></ref><ref id="B157-molecules-26-00632"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva Antonio</surname><given-names>A.</given-names></name><name><surname>Wiedemann</surname><given-names>L.S.M.</given-names></name><name><surname>Veiga-Junior</surname><given-names>V.F.</given-names></name></person-group><article-title>Natural products&#x02019; role against COVID-19</article-title><source>RSC Adv.</source><year>2020</year><volume>10</volume><fpage>23379</fpage><lpage>23393</lpage><pub-id pub-id-type="doi">10.1039/d0ra03774e</pub-id></element-citation></ref><ref id="B158-molecules-26-00632"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gendrot</surname><given-names>M.</given-names></name><name><surname>Andreani</surname><given-names>J.</given-names></name><name><surname>Boxberger</surname><given-names>M.</given-names></name><name><surname>Jardot</surname><given-names>P.</given-names></name><name><surname>Fonta</surname><given-names>I.</given-names></name><name><surname>Le Bideau</surname><given-names>M.</given-names></name><name><surname>Duflot</surname><given-names>I.</given-names></name><name><surname>Mosnier</surname><given-names>J.</given-names></name><name><surname>Rolland</surname><given-names>C.</given-names></name><name><surname>Bogreau</surname><given-names>H.</given-names></name></person-group><article-title>Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation</article-title><source>Travel Med. Infect. Dis.</source><year>2020</year><volume>37</volume><fpage>101873</fpage><pub-id pub-id-type="doi">10.1016/j.tmaid.2020.101873</pub-id><pub-id pub-id-type="pmid">32916297</pub-id></element-citation></ref><ref id="B159-molecules-26-00632"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name></person-group><article-title>A critical review: Traditional uses, phytochemistry, pharmacology and toxicology of <italic>Stephania tetrandra</italic> S. Moore (Fen Fang Ji)</article-title><source>Phytochem. Rev.</source><year>2020</year><volume>19</volume><fpage>449</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1007/s11101-020-09673-w</pub-id></element-citation></ref><ref id="B160-molecules-26-00632"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Baylink</surname><given-names>D.J.</given-names></name><name><surname>Chen</surname><given-names>C.-S.</given-names></name><name><surname>Reeves</surname><given-names>M.E.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name><name><surname>Lacy</surname><given-names>C.</given-names></name><name><surname>Lau</surname><given-names>E.</given-names></name><name><surname>Cao</surname><given-names>H.</given-names></name></person-group><article-title>The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19</article-title><source>J. Transl. Med.</source><year>2020</year><volume>18</volume><fpage>322</fpage><pub-id pub-id-type="doi">10.1186/s12967-020-02488-5</pub-id><pub-id pub-id-type="pmid">32847594</pub-id></element-citation></ref><ref id="B161-molecules-26-00632"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginde</surname><given-names>A.A.</given-names></name><name><surname>Blatchford</surname><given-names>P.</given-names></name><name><surname>Breese</surname><given-names>K.</given-names></name><name><surname>Zarrabi</surname><given-names>L.</given-names></name><name><surname>Linnebur</surname><given-names>S.A.</given-names></name><name><surname>Wallace</surname><given-names>J.I.</given-names></name><name><surname>Schwartz</surname><given-names>R.S.</given-names></name></person-group><article-title>High-Dose Monthly Vitamin D for Prevention of Acute Respiratory Infection in Older Long-Term Care Residents: A Randomized Clinical Trial</article-title><source>J. Am. Geriatr. Soc.</source><year>2017</year><volume>65</volume><fpage>496</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1111/jgs.14679</pub-id><pub-id pub-id-type="pmid">27861708</pub-id></element-citation></ref><ref id="B162-molecules-26-00632"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>DeGruttola</surname><given-names>V.</given-names></name><name><surname>Lei</surname><given-names>Q.</given-names></name><name><surname>Mayer</surname><given-names>K.H.</given-names></name><name><surname>Redline</surname><given-names>S.</given-names></name><name><surname>Hazra</surname><given-names>A.</given-names></name><name><surname>Mora</surname><given-names>S.</given-names></name><name><surname>Willett</surname><given-names>W.C.</given-names></name><name><surname>Ganmaa</surname><given-names>D.</given-names></name><name><surname>Manson</surname><given-names>J.E.</given-names></name></person-group><article-title>The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized design</article-title><source>Contemp. Clin. Trials</source><year>2021</year><volume>100</volume><fpage>106176</fpage><pub-id pub-id-type="doi">10.1016/j.cct.2020.106176</pub-id></element-citation></ref><ref id="B163-molecules-26-00632"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautret</surname><given-names>P.</given-names></name><name><surname>Lagier</surname><given-names>J.C.</given-names></name><name><surname>Parola</surname><given-names>P.</given-names></name><name><surname>Hoang</surname><given-names>V.T.</given-names></name><name><surname>Meddeb</surname><given-names>L.</given-names></name><name><surname>Mailhe</surname><given-names>M.</given-names></name><name><surname>Doudier</surname><given-names>B.</given-names></name><name><surname>Courjon</surname><given-names>J.</given-names></name><name><surname>Giordanengo</surname><given-names>V.</given-names></name><name><surname>Vieira</surname><given-names>V.E.</given-names></name><etal/></person-group><article-title>Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial</article-title><source>Int. J. Antimicrob. Agents</source><year>2020</year><volume>56</volume><fpage>105949</fpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105949</pub-id><?supplied-pmid 32205204?><pub-id pub-id-type="pmid">32205204</pub-id></element-citation></ref><ref id="B164-molecules-26-00632"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina</surname><given-names>J.-M.</given-names></name><name><surname>Delaugerre</surname><given-names>C.</given-names></name><name><surname>Le Goff</surname><given-names>J.</given-names></name><name><surname>Mela-Lima</surname><given-names>B.</given-names></name><name><surname>Ponscarme</surname><given-names>D.</given-names></name><name><surname>Goldwirt</surname><given-names>L.</given-names></name><name><surname>De Castro</surname><given-names>N.</given-names></name></person-group><article-title>No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection</article-title><source>Med. Mal. Infect.</source><year>2020</year><volume>50</volume><fpage>384</fpage><pub-id pub-id-type="doi">10.1016/j.medmal.2020.03.006</pub-id><?supplied-pmid 32240719?><pub-id pub-id-type="pmid">32240719</pub-id></element-citation></ref><ref id="B165-molecules-26-00632"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magagnoli</surname><given-names>J.</given-names></name><name><surname>Narendran</surname><given-names>S.</given-names></name><name><surname>Pereira</surname><given-names>F.</given-names></name><name><surname>Cummings</surname><given-names>T.H.</given-names></name><name><surname>Hardin</surname><given-names>J.W.</given-names></name><name><surname>Sutton</surname><given-names>S.S.</given-names></name><name><surname>Ambati</surname><given-names>J.</given-names></name></person-group><article-title>Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19</article-title><source>Med</source><year>2020</year><volume>1</volume><fpage>114.e3</fpage><lpage>127.e3</lpage><pub-id pub-id-type="doi">10.1016/j.medj.2020.06.001</pub-id><?supplied-pmid 32838355?><pub-id pub-id-type="pmid">32838355</pub-id></element-citation></ref><ref id="B166-molecules-26-00632"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Million</surname><given-names>M.</given-names></name><name><surname>Gautret</surname><given-names>P.</given-names></name><name><surname>Colson</surname><given-names>P.</given-names></name><name><surname>Roussel</surname><given-names>Y.</given-names></name><name><surname>Dubourg</surname><given-names>G.</given-names></name><name><surname>Chabriere</surname><given-names>E.</given-names></name><name><surname>Honore</surname><given-names>S.</given-names></name><name><surname>Rolain</surname><given-names>J.-M.</given-names></name><name><surname>Fenollar</surname><given-names>F.</given-names></name><name><surname>Fournier</surname><given-names>P.-E.</given-names></name><etal/></person-group><article-title>Clinical efficacy of chloroquine derivatives in COVID-19 infection: Comparative meta-analysis between the big data and the real world</article-title><source>New Microbes New Infect.</source><year>2020</year><volume>38</volume><fpage>100709</fpage><pub-id pub-id-type="doi">10.1016/j.nmni.2020.100709</pub-id><?supplied-pmid 33088574?><pub-id pub-id-type="pmid">33088574</pub-id></element-citation></ref><ref id="B167-molecules-26-00632"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>W.</given-names></name><name><surname>Cao</surname><given-names>Z.</given-names></name><name><surname>Han</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>W.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Xiao</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: Open label, randomised controlled trial</article-title><source>BMJ</source><year>2020</year><volume>369</volume><fpage>m1849</fpage><pub-id pub-id-type="doi">10.1136/bmj.m1849</pub-id><?supplied-pmid 32409561?><pub-id pub-id-type="pmid">32409561</pub-id></element-citation></ref><ref id="B168-molecules-26-00632"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Tian</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name></person-group><article-title>Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies</article-title><source>Biosci. Trends</source><year>2020</year><volume>14</volume><fpage>72</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.5582/bst.2020.01047</pub-id><?supplied-pmid 32074550?><pub-id pub-id-type="pmid">32074550</pub-id></element-citation></ref><ref id="B169-molecules-26-00632"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahevas</surname><given-names>M.</given-names></name><name><surname>Tran</surname><given-names>V.-T.</given-names></name><name><surname>Roumier</surname><given-names>M.</given-names></name><name><surname>Chabrol</surname><given-names>A.</given-names></name><name><surname>Paule</surname><given-names>R.</given-names></name><name><surname>Guillaud</surname><given-names>C.</given-names></name><name><surname>Gallien</surname><given-names>S.</given-names></name><name><surname>Lepeule</surname><given-names>R.</given-names></name><name><surname>Szwebel</surname><given-names>T.-A.</given-names></name><name><surname>Lescure</surname><given-names>X.</given-names></name></person-group><article-title>No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: Results of a study using routinely collected data to emulate a target trial</article-title><source>medRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.04.10.20060699</pub-id></element-citation></ref><ref id="B170-molecules-26-00632"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chorin</surname><given-names>E.</given-names></name><name><surname>Dai</surname><given-names>M.</given-names></name><name><surname>Shulman</surname><given-names>E.</given-names></name><name><surname>Wadhwani</surname><given-names>L.</given-names></name><name><surname>Bar Cohen</surname><given-names>R.</given-names></name><name><surname>Barbhaiya</surname><given-names>C.</given-names></name><name><surname>Aizer</surname><given-names>A.</given-names></name><name><surname>Holmes</surname><given-names>D.</given-names></name><name><surname>Bernstein</surname><given-names>S.</given-names></name><name><surname>Soinelli</surname><given-names>M.</given-names></name></person-group><article-title>The QT Interval in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine/Azithromycin</article-title><source>medRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.04.02.20047050</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-26-00632-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>2D structure of calcitriol (Vitamin D).</p></caption><graphic xlink:href="molecules-26-00632-g001"/></fig><fig id="molecules-26-00632-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>2D structure of ascorbic acid (Vitamin C).</p></caption><graphic xlink:href="molecules-26-00632-g002"/></fig><fig id="molecules-26-00632-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>3D crystal structure human lactoferrin (PDB: 1B0L) [<xref rid="B50-molecules-26-00632" ref-type="bibr">50</xref>]. Orange spheres represent Fe<sup>3+</sup> cation binding sites.</p></caption><graphic xlink:href="molecules-26-00632-g003"/></fig><fig id="molecules-26-00632-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>2D structure of quercetin.</p></caption><graphic xlink:href="molecules-26-00632-g004"/></fig><fig id="molecules-26-00632-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>2D structure of resveratrol.</p></caption><graphic xlink:href="molecules-26-00632-g005"/></fig><fig id="molecules-26-00632-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>2D structure of hanfangchin A (tetrandrine).</p></caption><graphic xlink:href="molecules-26-00632-g006"/></fig><fig id="molecules-26-00632-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>2D structure of glycyrrhizin.</p></caption><graphic xlink:href="molecules-26-00632-g007"/></fig><fig id="molecules-26-00632-f008" orientation="portrait" position="float"><label>Figure 8</label><caption><p>2D structure of artemisinin.</p></caption><graphic xlink:href="molecules-26-00632-g008"/></fig><fig id="molecules-26-00632-f009" orientation="portrait" position="float"><label>Figure 9</label><caption><p>2D structure of colchicine.</p></caption><graphic xlink:href="molecules-26-00632-g009"/></fig><fig id="molecules-26-00632-f010" orientation="portrait" position="float"><label>Figure 10</label><caption><p>2D structure of berberine.</p></caption><graphic xlink:href="molecules-26-00632-g010"/></fig><fig id="molecules-26-00632-f011" orientation="portrait" position="float"><label>Figure 11</label><caption><p>2D structures of (<bold>a</bold>) thalimonine and (<bold>b</bold>) sophaline.</p></caption><graphic xlink:href="molecules-26-00632-g011"/></fig><fig id="molecules-26-00632-f012" orientation="portrait" position="float"><label>Figure 12</label><caption><p>2D structures of (<bold>a</bold>) cryptomisrine, (<bold>b</bold>) cryptospirolepine, (<bold>c</bold>) cryptoquindoline, and (<bold>d</bold>) biscryptolepine.</p></caption><graphic xlink:href="molecules-26-00632-g012"/></fig><fig id="molecules-26-00632-f013" orientation="portrait" position="float"><label>Figure 13</label><caption><p>2D structures of (<bold>a</bold>) schizanthine Z and (<bold>b</bold>) schizanthine Y.</p></caption><graphic xlink:href="molecules-26-00632-g013"/></fig><fig id="molecules-26-00632-f014" orientation="portrait" position="float"><label>Figure 14</label><caption><p>2D structures of (<bold>a</bold>) anisotine, (<bold>b</bold>) quinadoline B and (<bold>c</bold>) scedapin C.</p></caption><graphic xlink:href="molecules-26-00632-g014"/></fig><fig id="molecules-26-00632-f015" orientation="portrait" position="float"><label>Figure 15</label><caption><p>2D structures of (<bold>a</bold>) glycyrrhetinic acid, (<bold>b</bold>) betulinic acid, (<bold>c</bold>) ursolic acid, (<bold>d</bold>) oleanolic acid.</p></caption><graphic xlink:href="molecules-26-00632-g015"/></fig><fig id="molecules-26-00632-f016" orientation="portrait" position="float"><label>Figure 16</label><caption><p>2D structures of (<bold>a</bold>) chenodeoxycholic acid, (<bold>b</bold>) ursodeoxycholic acid, (<bold>c</bold>) Glyco-ursodeoxycholic acid, (<bold>d</bold>) glyco-chenodeoxycholic acid, (<bold>e</bold>) withanolide N, (<bold>f</bold>) dihydrowithaferin A, (<bold>g</bold>) ashwagandhanolide, (<bold>h</bold>) withanoside X, (i) withanoside V.</p></caption><graphic xlink:href="molecules-26-00632-g016"/></fig><fig id="molecules-26-00632-f017" orientation="portrait" position="float"><label>Figure 17</label><caption><p>2D structures of (<bold>a</bold>) broussoflavonol F, (<bold>b</bold>) myricetin, (<bold>c</bold>) hesperetin, (<bold>d</bold>) quercetin, (<bold>e</bold>) kaempferol, (<bold>f</bold>) herbacetin, (<bold>g</bold>) tricetin, (<bold>h</bold>) nobiletin, (<bold>i</bold>) naringenin, (<bold>l</bold>) quercetin-3-<italic>O</italic>-galactosyl-rhamnosyl-glucoside, (<bold>m</bold>) rutin, (<bold>n</bold>) neohesperidin, (<bold>o</bold>) scutellarin, (<bold>p</bold>) quercetin-3-&#x003b2;-galactoside, (<bold>q</bold>) baicalin, (<bold>r</bold>) pectolinarin.</p></caption><graphic xlink:href="molecules-26-00632-g017"/></fig><fig id="molecules-26-00632-f018" orientation="portrait" position="float"><label>Figure 18</label><caption><p>2D structures of (<bold>a</bold>) embelin and (<bold>b</bold>) emodin.</p></caption><graphic xlink:href="molecules-26-00632-g018"/></fig><table-wrap id="molecules-26-00632-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-26-00632-t001_Table 1</object-id><label>Table 1</label><caption><p>Naturally occurring compounds recognizing SARS-CoV-2 druggable targets under investigation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Natural Sources</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">In Silico</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">In Vitro</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Clinical Trials</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alpha-spinasterol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Nigella sativa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B128-molecules-26-00632" ref-type="bibr">128</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anethole</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Fennel</italic>, <italic>anise</italic>, <italic>Star anise</italic>, <italic>Essential oils</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B120-molecules-26-00632" ref-type="bibr">120</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anisotine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Justicia adhatoda</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B113-molecules-26-00632" ref-type="bibr">113</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aronadendin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Onion</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B132-molecules-26-00632" ref-type="bibr">132</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arteannuin B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Artemisia annua</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B94-molecules-26-00632" ref-type="bibr">94</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Artemisinin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Artemisia Annua</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B93-molecules-26-00632" ref-type="bibr">93</xref>,<xref rid="B94-molecules-26-00632" ref-type="bibr">94</xref>,<xref rid="B158-molecules-26-00632" ref-type="bibr">158</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Artepillin C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Honey and propolis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B151-molecules-26-00632" ref-type="bibr">151</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ashwagandhanolide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Withania somnifera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B127-molecules-26-00632" ref-type="bibr">127</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Baicalin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Scutellaria baicalensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B135-molecules-26-00632" ref-type="bibr">135</xref>,<xref rid="B138-molecules-26-00632" ref-type="bibr">138</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Berberine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Berberis vulgaris</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B101-molecules-26-00632" ref-type="bibr">101</xref>,<xref rid="B102-molecules-26-00632" ref-type="bibr">102</xref>,<xref rid="B104-molecules-26-00632" ref-type="bibr">104</xref>,<xref rid="B105-molecules-26-00632" ref-type="bibr">105</xref>,<xref rid="B106-molecules-26-00632" ref-type="bibr">106</xref>,<xref rid="B107-molecules-26-00632" ref-type="bibr">107</xref>,<xref rid="B108-molecules-26-00632" ref-type="bibr">108</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Beta-sitosterol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Nigella sativa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B128-molecules-26-00632" ref-type="bibr">128</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Betulinic Acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Betula pubescens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B123-molecules-26-00632" ref-type="bibr">123</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biscryptolepine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cryptolepis sanguinolenta</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-molecules-26-00632" ref-type="bibr">110</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broussoflavonol F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Macaranga indica</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B137-molecules-26-00632" ref-type="bibr">137</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Campesterol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Nigella sativa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B128-molecules-26-00632" ref-type="bibr">128</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carvacrol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Origanum vulgare</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B120-molecules-26-00632" ref-type="bibr">120</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chenodeoxycholic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bile Acids</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B122-molecules-26-00632" ref-type="bibr">122</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cinnamaldehyde</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cinnamomum</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B120-molecules-26-00632" ref-type="bibr">120</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cinnamyl Acetate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Essential oils</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B120-molecules-26-00632" ref-type="bibr">120</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Citronellol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cymbopogon winterianus</italic>, <italic>Geranium</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B119-molecules-26-00632" ref-type="bibr">119</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Colchicine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Colchicum autumnale</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B99-molecules-26-00632" ref-type="bibr">99</xref>,<xref rid="B100-molecules-26-00632" ref-type="bibr">100</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cryptomisrine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cryptolepis sanguinolenta</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-molecules-26-00632" ref-type="bibr">110</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cryptoquindoline</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cryptolepis sanguinolenta</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-molecules-26-00632" ref-type="bibr">110</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cryptospirolepine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cryptolepis sanguinolenta</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-molecules-26-00632" ref-type="bibr">110</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cycloeucalenol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Nigella sativa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B128-molecules-26-00632" ref-type="bibr">128</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dihydrowithaferin A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Withania somnifera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B127-molecules-26-00632" ref-type="bibr">127</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ellagic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Honey and propolis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B151-molecules-26-00632" ref-type="bibr">151</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Embelin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Embelia ribes plant</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B146-molecules-26-00632" ref-type="bibr">146</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Emodin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Rheum officinale</italic> and <italic>Reynoutria multiflora</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B147-molecules-26-00632" ref-type="bibr">147</xref>,<xref rid="B148-molecules-26-00632" ref-type="bibr">148</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Geraniol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Essential oils</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B119-molecules-26-00632" ref-type="bibr">119</xref>,<xref rid="B120-molecules-26-00632" ref-type="bibr">120</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glico-chenodeoxycholic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bile Acids</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B122-molecules-26-00632" ref-type="bibr">122</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glyco-ursodeoxycholic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bile Acids</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B122-molecules-26-00632" ref-type="bibr">122</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycyrrhetinic Acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Glycyrrhiza glabra</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B123-molecules-26-00632" ref-type="bibr">123</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycyrrhizin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Glycyrrhiza glabra</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B89-molecules-26-00632" ref-type="bibr">89</xref>,<xref rid="B90-molecules-26-00632" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hanfangchin A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Stephania tetrandra</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-molecules-26-00632" ref-type="bibr">82</xref>,<xref rid="B83-molecules-26-00632" ref-type="bibr">83</xref>,<xref rid="B84-molecules-26-00632" ref-type="bibr">84</xref>,<xref rid="B88-molecules-26-00632" ref-type="bibr">88</xref>,<xref rid="B159-molecules-26-00632" ref-type="bibr">159</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Herbacetin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Rhodiola rosea</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B135-molecules-26-00632" ref-type="bibr">135</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hesperetin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Citrus</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B140-molecules-26-00632" ref-type="bibr">140</xref>,<xref rid="B141-molecules-26-00632" ref-type="bibr">141</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kaempferol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Aloe vera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B134-molecules-26-00632" ref-type="bibr">134</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L-4-terpineol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Essential oils</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B120-molecules-26-00632" ref-type="bibr">120</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lactoferrin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Mammalian and Animal milk</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B56-molecules-26-00632" ref-type="bibr">56</xref>,<xref rid="B57-molecules-26-00632" ref-type="bibr">57</xref>,<xref rid="B67-molecules-26-00632" ref-type="bibr">67</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leucopelargonidin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Onion</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B111-molecules-26-00632" ref-type="bibr">111</xref>,<xref rid="B132-molecules-26-00632" ref-type="bibr">132</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Limonene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Essential oils</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B119-molecules-26-00632" ref-type="bibr">119</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Limonin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Euodia rutaecarpa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B119-molecules-26-00632" ref-type="bibr">119</xref>,<xref rid="B120-molecules-26-00632" ref-type="bibr">120</xref>,<xref rid="B121-molecules-26-00632" ref-type="bibr">121</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Linalool</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Essential oils</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B119-molecules-26-00632" ref-type="bibr">119</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Myricetin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Onion</italic>, <italic>Chilli</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B132-molecules-26-00632" ref-type="bibr">132</xref>,<xref rid="B139-molecules-26-00632" ref-type="bibr">139</xref>,<xref rid="B140-molecules-26-00632" ref-type="bibr">140</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Naringenin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Citrus</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B138-molecules-26-00632" ref-type="bibr">138</xref>,<xref rid="B139-molecules-26-00632" ref-type="bibr">139</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neohesperidin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Citrus</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B138-molecules-26-00632" ref-type="bibr">138</xref>,<xref rid="B139-molecules-26-00632" ref-type="bibr">139</xref>,<xref rid="B141-molecules-26-00632" ref-type="bibr">141</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neryl Acetate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Citrus oils</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B119-molecules-26-00632" ref-type="bibr">119</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nobiletin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Citrus</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B138-molecules-26-00632" ref-type="bibr">138</xref>,<xref rid="B139-molecules-26-00632" ref-type="bibr">139</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oleanolic Acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Olea europaea</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B122-molecules-26-00632" ref-type="bibr">122</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pectolinarin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Cirsium setidens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B135-molecules-26-00632" ref-type="bibr">135</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pulegone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Essential oils</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B120-molecules-26-00632" ref-type="bibr">120</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quercetin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Onion</italic>, <italic>Garlic</italic>, <italic>Peppermint</italic>, <italic>Fenugreek</italic>, <italic>Origan</italic><break/><italic>Capers</italic>, <italic>Onions</italic>, <italic>Elderberries</italic>, <italic>Kale</italic>, <italic>Okra</italic>, <italic>Apple Peels</italic>, <italic>Aronia Berries</italic>, <italic>Cranberries</italic>, <italic>Asparagus</italic>, <italic>Goji Berries</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B10-molecules-26-00632" ref-type="bibr">10</xref>,<xref rid="B71-molecules-26-00632" ref-type="bibr">71</xref>,<xref rid="B132-molecules-26-00632" ref-type="bibr">132</xref>,<xref rid="B139-molecules-26-00632" ref-type="bibr">139</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quercetin-3-O-galactosyl-rhamnosyl-glucoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Withania somnifera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B127-molecules-26-00632" ref-type="bibr">127</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quercetin-3-&#x003b2;-galactoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Artemisia capillaris</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B136-molecules-26-00632" ref-type="bibr">136</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quinadoline B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Fungi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B114-molecules-26-00632" ref-type="bibr">114</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Red wine</italic>, <italic>Red grape juice</italic>, <italic>Peanuts</italic>, <italic>Fresh grapes</italic>, <italic>Pistachios</italic>, <italic>Peanut butter</italic>, <italic>Cocoa powder</italic>, <italic>Dark chocolate</italic>, <italic>Milk chocolate</italic>, <italic>Strawberries</italic>, <italic>Jackfruit skin</italic>, <italic>Blueberries</italic>, <italic>Bilberries</italic>, <italic>Red currants</italic>, <italic>Cranberries</italic>, <italic>Lingonberries</italic>, <italic>Mulberries</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B80-molecules-26-00632" ref-type="bibr">80</xref>,<xref rid="B81-molecules-26-00632" ref-type="bibr">81</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rutin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Citrus</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B139-molecules-26-00632" ref-type="bibr">139</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Scedapin C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Fungi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B114-molecules-26-00632" ref-type="bibr">114</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Schizanthine Y</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Schizanthus porrigens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B112-molecules-26-00632" ref-type="bibr">112</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Schizanthine Z</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Schizanthus porrigens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B112-molecules-26-00632" ref-type="bibr">112</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Scopadulcic Acid B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Scoparia dulcis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Scutellarin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Scutellaria barbata</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B139-molecules-26-00632" ref-type="bibr">139</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sophaline</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Sophora alopecuriodes</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B86-molecules-26-00632" ref-type="bibr">86</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thalimonine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Thalictrum simplex</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B86-molecules-26-00632" ref-type="bibr">86</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thymol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Essential oils</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B120-molecules-26-00632" ref-type="bibr">120</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tricetin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ginger</italic>, <italic>Onion</italic>, <italic>flowers of pomegranate.</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B132-molecules-26-00632" ref-type="bibr">132</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ursodeoxycholic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bile Acids</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B122-molecules-26-00632" ref-type="bibr">122</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ursolic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Bile Acids</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B122-molecules-26-00632" ref-type="bibr">122</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vitamin C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Citrus Fruit</italic>, <italic>Tropical Fruit</italic>, <italic>Peppers</italic>, <italic>Cruciferous Vegetables</italic>, <italic>Leafy Vegetables</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B36-molecules-26-00632" ref-type="bibr">36</xref>,<xref rid="B40-molecules-26-00632" ref-type="bibr">40</xref>,<xref rid="B41-molecules-26-00632" ref-type="bibr">41</xref>,<xref rid="B42-molecules-26-00632" ref-type="bibr">42</xref>,<xref rid="B43-molecules-26-00632" ref-type="bibr">43</xref>,<xref rid="B44-molecules-26-00632" ref-type="bibr">44</xref>,<xref rid="B45-molecules-26-00632" ref-type="bibr">45</xref>,<xref rid="B46-molecules-26-00632" ref-type="bibr">46</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vitamin D</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Human and Jay Jasmine plant</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B32-molecules-26-00632" ref-type="bibr">32</xref>,<xref rid="B33-molecules-26-00632" ref-type="bibr">33</xref>,<xref rid="B34-molecules-26-00632" ref-type="bibr">34</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Withanolide N</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Withania somnifera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B127-molecules-26-00632" ref-type="bibr">127</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Withanoside V</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Withania somnifera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B127-molecules-26-00632" ref-type="bibr">127</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Withanoside X</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Withania somnifera</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B127-molecules-26-00632" ref-type="bibr">127</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5<italic>S</italic>-5-Hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-3-heptanone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Ginger</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02022;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B132-molecules-26-00632" ref-type="bibr">132</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>